BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, Pachicano M, Joe E, Nelson AR, D'Orazio LM, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, Schneider LS, Morris JC, Reiman EM, Caselli RJ, Chui HC, Tcw J, Chen Y, Pa J, Conti PS, Law M, Toga AW, Zlokovic BV. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature 2020;581:71-6. [PMID: 32376954 DOI: 10.1038/s41586-020-2247-3] [Cited by in Crossref: 213] [Cited by in F6Publishing: 198] [Article Influence: 106.5] [Reference Citation Analysis]
Number Citing Articles
1 Robinson JL, Richardson H, Xie SX, Suh E, Van Deerlin VM, Alfaro B, Loh N, Porras-Paniagua M, Nirschl JJ, Wolk D, Lee VM, Lee EB, Trojanowski JQ. The development and convergence of co-pathologies in Alzheimer's disease. Brain 2021;144:953-62. [PMID: 33449993 DOI: 10.1093/brain/awaa438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Xiao M, Xiao ZJ, Yang B, Lan Z, Fang F. Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders. Front Neurosci 2020;14:764. [PMID: 32903669 DOI: 10.3389/fnins.2020.00764] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
3 Liu Q, Liu X, Zhao D, Ruan X, Su R, Shang X, Wang D, Yang C, Xue Y. Pseudogene ACTBP2 increases blood-brain barrier permeability by promoting KHDRBS2 transcription through recruitment of KMT2D/WDR5 in Aβ1-42 microenvironment. Cell Death Discov 2021;7:142. [PMID: 34127651 DOI: 10.1038/s41420-021-00531-y] [Reference Citation Analysis]
4 Keable A, O'Neill R, MacGregor Sharp M, Gatherer M, Yuen HM, Johnston DA, Weller RO, Carare RO. ApoE4 Astrocytes Secrete Basement Membranes Rich in Fibronectin and Poor in Laminin Compared to ApoE3 Astrocytes. Int J Mol Sci 2020;21:E4371. [PMID: 32575521 DOI: 10.3390/ijms21124371] [Reference Citation Analysis]
5 Pickering J, Wong R, Al-Salami H, Lam V, Takechi R. Cognitive Deficits in Type-1 Diabetes: Aspects of Glucose, Cerebrovascular and Amyloid Involvement. Pharm Res 2021;38:1477-84. [PMID: 34480263 DOI: 10.1007/s11095-021-03100-1] [Reference Citation Analysis]
6 Bhattacharya A, Kaushik DK, Lozinski BM, Yong VW. Beyond barrier functions: Roles of pericytes in homeostasis and regulation of neuroinflammation. J Neurosci Res 2020;98:2390-405. [PMID: 32815569 DOI: 10.1002/jnr.24715] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Banks WA, Reed MJ, Logsdon AF, Rhea EM, Erickson MA. Healthy aging and the blood-brain barrier. Nat Aging 2021;1:243-54. [PMID: 34368785 DOI: 10.1038/s43587-021-00043-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
8 Watanabe R, Hashimoto M. Aging-Related Vascular Inflammation: Giant Cell Arteritis and Neurological Disorders. Front Aging Neurosci 2022;14:843305. [DOI: 10.3389/fnagi.2022.843305] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Higgins-Chen AT, Thrush KL, Levine ME. Aging biomarkers and the brain. Semin Cell Dev Biol 2021;116:180-93. [PMID: 33509689 DOI: 10.1016/j.semcdb.2021.01.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Fink A, Doblhammer G, Tamgüney G. Recurring Gastrointestinal Infections Increase the Risk of Dementia. J Alzheimers Dis 2021;84:797-806. [PMID: 34602468 DOI: 10.3233/JAD-210316] [Reference Citation Analysis]
11 Pritchard AB, Fabian Z, Lawrence CL, Morton G, Crean S, Alder JE. An Investigation into the Effects of Outer Membrane Vesicles and Lipopolysaccharide of Porphyromonas gingivalis on Blood-Brain Barrier Integrity, Permeability, and Disruption of Scaffolding Proteins in a Human in vitro Model. J Alzheimers Dis 2022;86:343-64. [PMID: 35034897 DOI: 10.3233/JAD-215054] [Reference Citation Analysis]
12 Picca A, Guerra F, Calvani R, Coelho-Júnior HJ, Landi F, Bernabei R, Romano R, Bucci C, Marzetti E. Extracellular Vesicles and Damage-Associated Molecular Patterns: A Pandora's Box in Health and Disease. Front Immunol 2020;11:601740. [PMID: 33304353 DOI: 10.3389/fimmu.2020.601740] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
13 Huuskonen MT, Barisano G, Chakhoyan A, Zlokovic BV. Editorial for "MRI-Based Investigation of Association Between Cerebrovascular Structural Alteration and White Matter Hyperintensity Induced by High Blood Pressure". J Magn Reson Imaging 2021. [PMID: 34331486 DOI: 10.1002/jmri.27854] [Reference Citation Analysis]
14 Barisano G, Montagne A, Kisler K, Schneider JA, Wardlaw JM, Zlokovic BV. Blood-brain barrier link to human cognitive impairment and Alzheimer's Disease. Nat Cardiovasc Res 2022;1:108-15. [PMID: 35450117 DOI: 10.1038/s44161-021-00014-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Little K, Llorián-Salvador M, Scullion S, Hernández C, Simó-Servat O, Del Marco A, Bosma E, Vargas-Soria M, Carranza-Naval MJ, Van Bergen T, Galbiati S, Viganò I, Musi CA, Schlingemann R, Feyen J, Borsello T, Zerbini G, Klaassen I, Garcia-Alloza M, Simó R, Stitt AW; RECOGNISED consortium (GA 847749). Common pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive decline. Trends Endocrinol Metab 2022;33:50-71. [PMID: 34794851 DOI: 10.1016/j.tem.2021.10.008] [Reference Citation Analysis]
16 Begemann M, Gross O, Wincewicz D, Hardeland R, Daguano Gastaldi V, Vieta E, Weissenborn K, Miskowiak KW, Moerer O, Ehrenreich H. Addressing the 'hypoxia paradox' in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues. Mol Med 2021;27:120. [PMID: 34565332 DOI: 10.1186/s10020-021-00381-5] [Reference Citation Analysis]
17 Stringer MS, Lee H, Huuskonen MT, MacIntosh BJ, Brown R, Montagne A, Atwi S, Ramirez J, Jansen MA, Marshall I, Black SE, Zlokovic BV, Benveniste H, Wardlaw JM. A Review of Translational Magnetic Resonance Imaging in Human and Rodent Experimental Models of Small Vessel Disease. Transl Stroke Res 2021;12:15-30. [PMID: 32936435 DOI: 10.1007/s12975-020-00843-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Mok VCT, Pendlebury S, Wong A, Alladi S, Au L, Bath PM, Biessels GJ, Chen C, Cordonnier C, Dichgans M, Dominguez J, Gorelick PB, Kim S, Kwok T, Greenberg SM, Jia J, Kalaria R, Kivipelto M, Naegandran K, Lam LCW, Lam BYK, Lee ATC, Markus HS, O'Brien J, Pai MC, Pantoni L, Sachdev P, Skoog I, Smith EE, Srikanth V, Suh GH, Wardlaw J, Ko H, Black SE, Scheltens P. Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future. Alzheimers Dement 2020;16:1571-81. [PMID: 32789951 DOI: 10.1002/alz.12143] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 15.0] [Reference Citation Analysis]
19 Alvariño R, Alfonso A, Pech-Puch D, Gegunde S, Rodríguez J, Vieytes MR, Jiménez C, Botana LM. Furanoditerpenes from Spongia (Spongia) tubulifera Display Mitochondrial-Mediated Neuroprotective Effects by Targeting Cyclophilin D. ACS Chem Neurosci 2022. [PMID: 35901231 DOI: 10.1021/acschemneuro.2c00208] [Reference Citation Analysis]
20 Dai L, Shen Y. Insights into T-cell dysfunction in Alzheimer's disease. Aging Cell 2021;20:e13511. [PMID: 34725916 DOI: 10.1111/acel.13511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Do Carmo S, Kannel B, Cuello AC. Nerve Growth Factor Compromise in Down Syndrome. Front Aging Neurosci 2021;13:719507. [PMID: 34434101 DOI: 10.3389/fnagi.2021.719507] [Reference Citation Analysis]
22 Li S, Qu L, Wang X, Kong L. Novel insights into RIPK1 as a promising target for future Alzheimer's disease treatment. Pharmacol Ther 2021;:107979. [PMID: 34480965 DOI: 10.1016/j.pharmthera.2021.107979] [Reference Citation Analysis]
23 Ni R. Magnetic Resonance Imaging in Animal Models of Alzheimer's Disease Amyloidosis. Int J Mol Sci 2021;22:12768. [PMID: 34884573 DOI: 10.3390/ijms222312768] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Coughlan G, Zhukovsky P, Voineskos A, Grady C. A profile of brain reserve in adults at genetic risk of Alzheimer's disease. Alzheimers Dement (Amst) 2021;13:e12208. [PMID: 34136636 DOI: 10.1002/dad2.12208] [Reference Citation Analysis]
25 Avila J, Perry G. A Multilevel View of the Development of Alzheimer's Disease. Neuroscience 2021;457:283-93. [PMID: 33246061 DOI: 10.1016/j.neuroscience.2020.11.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
26 Chen D, Fang X, Zhu Z. Progress in the correlation of postoperative cognitive dysfunction and Alzheimer's disease and the potential therapeutic drug exploration. Ibrain. [DOI: 10.1002/ibra.12040] [Reference Citation Analysis]
27 Kaufman CS, Morris JK, Vidoni ED, Burns JM, Billinger SA. Apolipoprotein E4 Moderates the Association Between Vascular Risk Factors and Brain Pathology. Alzheimer Dis Assoc Disord 2021;35:223-9. [PMID: 33734100 DOI: 10.1097/WAD.0000000000000442] [Reference Citation Analysis]
28 Margetts G, Kleidonas S, Zaibi NS, Zaibi MS, Edwards KD. Evidence for anti-inflammatory effects and modulation of neurotransmitter metabolism by Salvia officinalis L. BMC Complement Med Ther 2022;22:131. [PMID: 35550086 DOI: 10.1186/s12906-022-03605-1] [Reference Citation Analysis]
29 Foley KE, Hewes AA, Garceau DT, Kotredes KP, Carter GW, Sasner M, Howell GR. The APOEε3/ε4 Genotype Drives Distinct Gene Signatures in the Cortex of Young Mice. Front Aging Neurosci 2022;14:838436. [DOI: 10.3389/fnagi.2022.838436] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
30 Price BR, Johnson LA, Norris CM. Reactive astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer's disease. Ageing Res Rev 2021;68:101335. [PMID: 33812051 DOI: 10.1016/j.arr.2021.101335] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 18.0] [Reference Citation Analysis]
31 Presa JL, Saravia F, Bagi Z, Filosa JA. Vasculo-Neuronal Coupling and Neurovascular Coupling at the Neurovascular Unit: Impact of Hypertension. Front Physiol 2020;11:584135. [PMID: 33101063 DOI: 10.3389/fphys.2020.584135] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
32 Lindblad C, Pin E, Just D, Al Nimer F, Nilsson P, Bellander BM, Svensson M, Piehl F, Thelin EP. Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood-brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study. Crit Care 2021;25:103. [PMID: 33712077 DOI: 10.1186/s13054-021-03503-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
33 Rudge JD. A New Hypothesis for Alzheimer’s Disease: The Lipid Invasion Model. ADR 2022. [DOI: 10.3233/adr-210299] [Reference Citation Analysis]
34 Ojo JO, Reed JM, Crynen G, Vallabhaneni P, Evans J, Shackleton B, Eisenbaum M, Ringland C, Edsell A, Mullan M, Crawford F, Bachmeier C. Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy. Front Aging Neurosci 2021;13:658605. [PMID: 34079449 DOI: 10.3389/fnagi.2021.658605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Peoples N, Strang C. Complement Activation in the Central Nervous System: A Biophysical Model for Immune Dysregulation in the Disease State. Front Mol Neurosci 2021;14:620090. [PMID: 33746710 DOI: 10.3389/fnmol.2021.620090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Cohen-Salmon M, Slaoui L, Mazaré N, Gilbert A, Oudart M, Alvear-Perez R, Elorza-Vidal X, Chever O, Boulay AC. Astrocytes in the regulation of cerebrovascular functions. Glia 2021;69:817-41. [PMID: 33058289 DOI: 10.1002/glia.23924] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
37 Chong JR, Ashton NJ, Karikari TK, Tanaka T, Saridin FN, Reilhac A, Robins EG, Nai YH, Vrooman H, Hilal S, Zetterberg H, Blennow K, Lai MKP, Chen CP. Plasma P-tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease. Alzheimers Dement 2021. [PMID: 33792168 DOI: 10.1002/alz.12332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Kalaria RN, Sepulveda-Falla D. Cerebral Small Vessel Disease in Sporadic and Familial Alzheimer Disease. Am J Pathol 2021:S0002-9440(21)00341-2. [PMID: 34331941 DOI: 10.1016/j.ajpath.2021.07.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Pokhilko A, Brezzo G, Handunnetthi L, Heilig R, Lennon R, Smith C, Allan SM, Granata A, Sinha S, Wang T, Markus HS, Naba A, Fischer R, Van Agtmael T, Horsburgh K, Cader MZ. Global proteomic analysis of extracellular matrix in mouse and human brain highlights relevance to cerebrovascular disease. J Cereb Blood Flow Metab 2021;41:2423-38. [PMID: 33730931 DOI: 10.1177/0271678X211004307] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Chandler H, Wise R, Linden D, Williams J, Murphy K, Lancaster T. Alzheimer's genetic risk effects on cerebral blood flow across the lifespan are proximal to gene expression. Neurobiology of Aging 2022. [DOI: 10.1016/j.neurobiolaging.2022.08.001] [Reference Citation Analysis]
41 Fessel J. Does synaptic hypometabolism or synaptic dysfunction, originate cognitive loss? Analysis of the evidence. Alzheimers Dement (N Y) 2021;7:e12177. [PMID: 34027027 DOI: 10.1002/trc2.12177] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Gamache J, Yun Y, Chiba-Falek O. Sex-dependent effect of APOE on Alzheimer's disease and other age-related neurodegenerative disorders. Dis Model Mech 2020;13:dmm045211. [PMID: 32859588 DOI: 10.1242/dmm.045211] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
43 Wang J, Sun T, Zhang Y, Yu X, Wang H. Distinct Effects of the Apolipoprotein E ε4 Genotype on Associations Between Delayed Recall Performance and Resting-State Electroencephalography Theta Power in Elderly People Without Dementia. Front Aging Neurosci 2022;14:830149. [DOI: 10.3389/fnagi.2022.830149] [Reference Citation Analysis]
44 Conole ELS, Stevenson AJ, Muñoz Maniega S, Harris SE, Green C, Valdés Hernández MDC, Harris MA, Bastin ME, Wardlaw JM, Deary IJ, Miron VE, Whalley HC, Marioni RE, Cox SR. DNA Methylation and Protein Markers of Chronic Inflammation and Their Associations With Brain and Cognitive Aging. Neurology 2021;97:e2340-52. [PMID: 34789543 DOI: 10.1212/WNL.0000000000012997] [Reference Citation Analysis]
45 Bernal J, Valdés-Hernández MDC, Escudero J, Heye AK, Sakka E, Armitage PA, Makin S, Touyz RM, Wardlaw JM, Thrippleton MJ. A four-dimensional computational model of dynamic contrast-enhanced magnetic resonance imaging measurement of subtle blood-brain barrier leakage. Neuroimage 2021;230:117786. [PMID: 33497771 DOI: 10.1016/j.neuroimage.2021.117786] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Parodi-Rullán R, Ghiso J, Cabrera E, Rostagno A, Fossati S. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis. Aging Cell 2020;19:e13258. [PMID: 33155752 DOI: 10.1111/acel.13258] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
47 Wang J, Liu X, Du X, Ma Z, Liu B, Guo R, Feng B, Ma J, Cui H. Induced pluripotent stem cells derived from one 70-years-old male donor with the APOE-ε4/ε4 alleles. Stem Cell Res 2021;53:102395. [PMID: 34088020 DOI: 10.1016/j.scr.2021.102395] [Reference Citation Analysis]
48 Leaston J, Qiao J, Harding IC, Kulkarni P, Gharagouzloo C, Ebong E, Ferris CF. Quantitative Imaging of Blood-Brain Barrier Permeability Following Repetitive Mild Head Impacts. Front Neurol 2021;12:729464. [PMID: 34659094 DOI: 10.3389/fneur.2021.729464] [Reference Citation Analysis]
49 Perea JR, Bolós M, Avila J. Microglia in Alzheimer's Disease in the Context of Tau Pathology. Biomolecules 2020;10:E1439. [PMID: 33066368 DOI: 10.3390/biom10101439] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
50 Steinman J, Sun HS, Feng ZP. Microvascular Alterations in Alzheimer's Disease. Front Cell Neurosci 2020;14:618986. [PMID: 33536876 DOI: 10.3389/fncel.2020.618986] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
51 Wooten T, Brown E, Sullivan DR, Logue MW, Fortier CB, Fonda JR, DeGutis J, Salat DH, McGlinchey R, Milberg W, Esterman M. Apolipoprotein E (APOE) ε4 moderates the relationship between c-reactive protein, cognitive functioning, and white matter integrity. Brain Behav Immun 2021;95:84-95. [PMID: 33631288 DOI: 10.1016/j.bbi.2021.02.016] [Reference Citation Analysis]
52 Beard DJ, Brown LS, Sutherland BA. The rise of pericytes in neurovascular research. J Cereb Blood Flow Metab 2020;40:2366-73. [PMID: 32955956 DOI: 10.1177/0271678X20958497] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Jung Y, Viviano RP, van Rooden S, van der Grond J, Rombouts SARB, Damoiseaux JS. White Matter Hyperintensities and Apolipoprotein E Affect the Association Between Mean Arterial Pressure and Objective and Subjective Cognitive Functioning in Older Adults. J Alzheimers Dis 2021;84:1337-50. [PMID: 34657884 DOI: 10.3233/JAD-210695] [Reference Citation Analysis]
54 Anderson EL, Williams DM, Walker VM, Davies NM. Little genomic support for Cyclophilin A-matrix metalloproteinase-9 pathway as a therapeutic target for cognitive impairment in APOE4 carriers. Sci Rep 2022;12:1057. [PMID: 35058547 DOI: 10.1038/s41598-022-05225-8] [Reference Citation Analysis]
55 Patabendige A, Singh A, Jenkins S, Sen J, Chen R. Astrocyte Activation in Neurovascular Damage and Repair Following Ischaemic Stroke. Int J Mol Sci 2021;22:4280. [PMID: 33924191 DOI: 10.3390/ijms22084280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
56 Watanabe C, Imaizumi T, Kawai H, Suda K, Honma Y, Ichihashi M, Ema M, Mizutani KI. Aging of the Vascular System and Neural Diseases. Front Aging Neurosci 2020;12:557384. [PMID: 33132896 DOI: 10.3389/fnagi.2020.557384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
57 Casoli T. SARS-CoV-2 Morbidity in the CNS and the Aged Brain Specific Vulnerability. Int J Mol Sci 2022;23:3782. [PMID: 35409141 DOI: 10.3390/ijms23073782] [Reference Citation Analysis]
58 Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM. Alzheimer's disease. Lancet 2021;397:1577-90. [PMID: 33667416 DOI: 10.1016/S0140-6736(20)32205-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 39.0] [Reference Citation Analysis]
59 Ni K, Zhu J, Xu X, Liu Y, Yang S, Huang Y, Xu R, Jiang L, Zhang J, Zhang W, Ma Z. Hippocampal Activated Microglia May Contribute to Blood–Brain Barrier Impairment and Cognitive Dysfunction in Post-Traumatic Stress Disorder-Like Rats. J Mol Neurosci. [DOI: 10.1007/s12031-022-01981-4] [Reference Citation Analysis]
60 Zhang Q, Song Q, Gu X, Zheng M, Wang A, Jiang G, Huang M, Chen H, Qiu Y, Bo B, Tong S, Shao R, Li B, Wang G, Wang H, Hu Y, Chen H, Gao X. Multifunctional Nanostructure RAP-RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit. Adv Sci (Weinh) 2021;8:2001918. [PMID: 33511002 DOI: 10.1002/advs.202001918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Sun HL, Chen SH, Yu ZY, Cheng Y, Tian DY, Fan DY, He CY, Wang J, Sun PY, Chen Y, Tan CR, Wang JP, Song W, Zhou HD, Chen XW, Hu ZA, Bu XL, Wang YJ. Blood cell-produced amyloid-β induces cerebral Alzheimer-type pathologies and behavioral deficits. Mol Psychiatry 2020. [PMID: 32681097 DOI: 10.1038/s41380-020-0842-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
62 Bonvento G, Bolaños JP. Astrocyte-neuron metabolic cooperation shapes brain activity. Cell Metab 2021;33:1546-64. [PMID: 34348099 DOI: 10.1016/j.cmet.2021.07.006] [Reference Citation Analysis]
63 Littau JL, Velilla L, Hase Y, Villalba-Moreno ND, Hagel C, Drexler D, Osorio Restrepo S, Villegas A, Lopera F, Vargas S, Glatzel M, Krasemann S, Quiroz YT, Arboleda-Velasquez JF, Kalaria R, Sepulveda-Falla D. Evidence of beta amyloid independent small vessel disease in familial Alzheimer's disease. Brain Pathol 2022;:e13097. [PMID: 35695802 DOI: 10.1111/bpa.13097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Robb WH, Khan OA, Ahmed HA, Li J, Moore EE, Cambronero FE, Pechman KR, Liu D, Gifford KA, Landman BA, Donahue MJ, Hohman TJ, Jefferson AL. Lower cerebral oxygen utilization is associated with Alzheimer's disease-related neurodegeneration and poorer cognitive performance among apolipoprotein E ε4 carriers. J Cereb Blood Flow Metab 2021;:271678X211056393. [PMID: 34743630 DOI: 10.1177/0271678X211056393] [Reference Citation Analysis]
65 Hamilton OKL, Backhouse EV, Janssen E, Jochems ACC, Maher C, Ritakari TE, Stevenson AJ, Xia L, Deary IJ, Wardlaw JM. Cognitive impairment in sporadic cerebral small vessel disease: A systematic review and meta-analysis. Alzheimers Dement 2021;17:665-85. [PMID: 33185327 DOI: 10.1002/alz.12221] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
66 Ding R, Hase Y, Burke M, Foster V, Stevenson W, Polvikoski T, Kalaria RN. Loss with ageing but preservation of frontal cortical capillary pericytes in post-stroke dementia, vascular dementia and Alzheimer's disease. Acta Neuropathol Commun 2021;9:130. [PMID: 34340718 DOI: 10.1186/s40478-021-01230-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
67 Ciampa I, Operto G, Falcon C, Minguillon C, Castro de Moura M, Piñeyro D, Esteller M, Molinuevo JL, Guigó R, Navarro A, Gispert JD, Vilor-Tejedor N, For The Alfa Study. Genetic Predisposition to Alzheimer's Disease Is Associated with Enlargement of Perivascular Spaces in Centrum Semiovale Region. Genes (Basel) 2021;12:825. [PMID: 34072165 DOI: 10.3390/genes12060825] [Reference Citation Analysis]
68 Mirzaei N, Shi H, Oviatt M, Doustar J, Rentsendorj A, Fuchs DT, Sheyn J, Black KL, Koronyo Y, Koronyo-Hamaoui M. Alzheimer's Retinopathy: Seeing Disease in the Eyes. Front Neurosci 2020;14:921. [PMID: 33041751 DOI: 10.3389/fnins.2020.00921] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
69 Kirabali T, Rust R, Rigotti S, Siccoli A, Nitsch RM, Kulic L. Distinct changes in all major components of the neurovascular unit across different neuropathological stages of Alzheimer's disease. Brain Pathol 2020;30:1056-70. [PMID: 32866303 DOI: 10.1111/bpa.12895] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
70 Bonfili L, Cecarini V, Gogoi O, Gong C, Cuccioloni M, Angeletti M, Rossi G, Eleuteri AM. Microbiota modulation as preventative and therapeutic approach in Alzheimer's disease. FEBS J 2021;288:2836-55. [PMID: 32969566 DOI: 10.1111/febs.15571] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
71 Andrews EJ, Martini AC, Head E. Exploring the role of sex differences in Alzheimer's disease pathogenesis in Down syndrome. Front Neurosci 2022;16:954999. [DOI: 10.3389/fnins.2022.954999] [Reference Citation Analysis]
72 Botchway BO, Okoye FC, Chen Y, Arthur WE, Fang M. Alzheimer Disease: Recent Updates on Apolipoprotein E and Gut Microbiome Mediation of Oxidative Stress, and Prospective Interventional Agents. Aging Dis 2022;13:87-102. [PMID: 35111364 DOI: 10.14336/AD.2021.0616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
73 Li J, Zhang Q, Che Y, Zhang N, Guo L. Iron Deposition Characteristics of Deep Gray Matter in Elderly Individuals in the Community Revealed by Quantitative Susceptibility Mapping and Multiple Factor Analysis. Front Aging Neurosci 2021;13:611891. [PMID: 33935681 DOI: 10.3389/fnagi.2021.611891] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Albrecht DS, Sagare A, Pachicano M, Sweeney MD, Toga A, Zlokovic B, Chui H, Joe E, Schneider L, Morris JC, Benzinger T, Pa J. Early neuroinflammation is associated with lower amyloid and tau levels in cognitively normal older adults. Brain Behav Immun 2021;94:299-307. [PMID: 33486003 DOI: 10.1016/j.bbi.2021.01.010] [Reference Citation Analysis]
75 Jeon MT, Kim KS, Kim ES, Lee S, Kim J, Hoe HS, Kim DG. Emerging pathogenic role of peripheral blood factors following BBB disruption in neurodegenerative disease. Ageing Res Rev 2021;68:101333. [PMID: 33774194 DOI: 10.1016/j.arr.2021.101333] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
76 Qian J, Betensky RA, Hyman BT, Serrano-Pozo A. Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease. Neurology 2021;96:e2414-28. [PMID: 33771840 DOI: 10.1212/WNL.0000000000011883] [Reference Citation Analysis]
77 Uchida Y, Kan H, Sakurai K, Horimoto Y, Hayashi E, Iida A, Okamura N, Oishi K, Matsukawa N. APOE ɛ4 dose associates with increased brain iron and β-amyloid via blood-brain barrier dysfunction. J Neurol Neurosurg Psychiatry 2022:jnnp-2021-328519. [PMID: 35483916 DOI: 10.1136/jnnp-2021-328519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Kaufman CS, Honea RA, Pleen J, Lepping RJ, Watts A, Morris JK, Billinger SA, Burns JM, Vidoni ED. Aerobic exercise improves hippocampal blood flow for hypertensive Apolipoprotein E4 carriers. J Cereb Blood Flow Metab 2021;41:2026-37. [PMID: 33509035 DOI: 10.1177/0271678X21990342] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
79 Picca A, Calvani R, Coelho-Junior HJ, Landi F, Bernabei R, Marzetti E. Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration. Antioxidants (Basel) 2020;9:E647. [PMID: 32707949 DOI: 10.3390/antiox9080647] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 17.0] [Reference Citation Analysis]
80 Stringer MS, Heye AK, Armitage PA, Chappell F, Valdés Hernández MDC, Makin SDJ, Sakka E, Thrippleton MJ, Wardlaw JM. Tracer kinetic assessment of blood-brain barrier leakage and blood volume in cerebral small vessel disease: Associations with disease burden and vascular risk factors. Neuroimage Clin 2021;32:102883. [PMID: 34911189 DOI: 10.1016/j.nicl.2021.102883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
81 Zhou XB, Zhang YX, Zhou CX, Ma JJ. Chinese Herbal Medicine Adjusting Brain Microenvironment via Mediating Central Nervous System Lymphatic Drainage in Alzheimer's Disease. Chin J Integr Med 2021. [PMID: 34731433 DOI: 10.1007/s11655-021-3342-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Sharma S, Brown CE. Microvascular basis of cognitive impairment in type 1 diabetes. Pharmacol Ther 2021;:107929. [PMID: 34171341 DOI: 10.1016/j.pharmthera.2021.107929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Bertholf RL. Is Alzheimer Disease an Autoimmune Disorder? J Appl Lab Med 2021;6:588-91. [PMID: 33517411 DOI: 10.1093/jalm/jfaa235] [Reference Citation Analysis]
84 Smith LK, Verovskaya E, Bieri G, Horowitz AM, von Ungern-Sternberg SNI, Lin K, Seizer P, Passegué E, Villeda SA. The aged hematopoietic system promotes hippocampal-dependent cognitive decline. Aging Cell 2020;19:e13192. [PMID: 33073926 DOI: 10.1111/acel.13192] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
85 Wu CY, Shapiro L, Ouk M, MacIntosh BJ, Black SE, Shah BR, Swardfager W. Glucose-lowering drugs, cognition, and dementia: The clinical evidence. Neurosci Biobehav Rev 2022;137:104654. [PMID: 35398114 DOI: 10.1016/j.neubiorev.2022.104654] [Reference Citation Analysis]
86 Zlokovic BV, Gottesman RF, Bernstein KE, Seshadri S, McKee A, Snyder H, Greenberg SM, Yaffe K, Schaffer CB, Yuan C, Hughes TM, Daemen MJ, Williamson JD, González HM, Schneider J, Wellington CL, Katusic ZS, Stoeckel L, Koenig JI, Corriveau RA, Fine L, Galis ZS, Reis J, Wright JD, Chen J. Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop. Alzheimers Dement 2020;16:1714-33. [PMID: 33030307 DOI: 10.1002/alz.12157] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
87 Dumitrascu OM, Rosenberry R, Sherman DS, Khansari MM, Sheyn J, Torbati T, Sherzai A, Sherzai D, Johnson KO, Czeszynski AD, Verdooner S, Black KL, Frautschy S, Lyden PD, Shi Y, Cheng S, Koronyo Y, Koronyo-Hamaoui M. Retinal Venular Tortuosity Jointly with Retinal Amyloid Burden Correlates with Verbal Memory Loss: A Pilot Study. Cells 2021;10:2926. [PMID: 34831149 DOI: 10.3390/cells10112926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Hardingham GE, Petzold GC, Mehta AR. What astrocytes need to do. Lancet Neurol 2021;20:260. [PMID: 33743235 DOI: 10.1016/S1474-4422(21)00070-3] [Reference Citation Analysis]
89 Li X, Zhang Y, Chen X, Yuan H, Wang Z, Wang G, Zhang K, Liu H. Association of Gene Polymorphisms in APOE and BIN1 With Dementia of Alzheimer's Type Susceptibility in Chinese Han Population. Front Psychiatry 2021;12:753909. [PMID: 34733192 DOI: 10.3389/fpsyt.2021.753909] [Reference Citation Analysis]
90 Elahi FM, Ashimatey SB, Bennett DJ, Walters SM, La Joie R, Jiang X, Wolf A, Cobigo Y, Staffaroni AM, Rosen HJ, Miller BL, Rabinovici GD, Kramer JH, Green AJ, Kashani AH. Retinal imaging demonstrates reduced capillary density in clinically unimpaired APOE ε4 gene carriers. Alzheimers Dement (Amst) 2021;13:e12181. [PMID: 34013017 DOI: 10.1002/dad2.12181] [Reference Citation Analysis]
91 Dounavi ME, Low A, McKiernan EF, Mak E, Muniz-Terrera G, Ritchie K, Ritchie CW, Su L, O'Brien JT. Evidence of cerebral hemodynamic dysregulation in middle-aged APOE ε4 carriers: The PREVENT-Dementia study. J Cereb Blood Flow Metab 2021;:271678X211020863. [PMID: 34078163 DOI: 10.1177/0271678X211020863] [Reference Citation Analysis]
92 Guebel DV, Torres NV, Acebes Á. Mapping the transcriptomic changes of endothelial compartment in human hippocampus across aging and mild cognitive impairment. Biol Open 2021;10:bio057950. [PMID: 34184731 DOI: 10.1242/bio.057950] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Sharma HS, Muresanu DF, Castellani RJ, Nozari A, Lafuente JV, Buzoianu AD, Sahib S, Tian ZR, Bryukhovetskiy I, Manzhulo I, Menon PK, Patnaik R, Wiklund L, Sharma A. Alzheimer's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta peptide. Prog Brain Res 2021;265:1-97. [PMID: 34560919 DOI: 10.1016/bs.pbr.2021.04.008] [Reference Citation Analysis]
94 Xu W, Bai Q, Dong Q, Guo M, Cui M. Blood–Brain Barrier Dysfunction and the Potential Mechanisms in Chronic Cerebral Hypoperfusion Induced Cognitive Impairment. Front Cell Neurosci 2022;16:870674. [DOI: 10.3389/fncel.2022.870674] [Reference Citation Analysis]
95 Gong M, Jia J. Contribution of blood-brain barrier-related blood-borne factors for Alzheimer’s disease vs. vascular dementia diagnosis: A pilot study. Front Neurosci 2022;16:949129. [DOI: 10.3389/fnins.2022.949129] [Reference Citation Analysis]
96 Duong MT, Nasrallah IM, Wolk DA, Chang CCY, Chang TY. Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy. Front Aging Neurosci 2021;13:647990. [PMID: 33841127 DOI: 10.3389/fnagi.2021.647990] [Reference Citation Analysis]
97 Vikner T, Eklund A, Karalija N, Malm J, Riklund K, Lindenberger U, Bäckman L, Nyberg L, Wåhlin A. Cerebral arterial pulsatility is linked to hippocampal microvascular function and episodic memory in healthy older adults. J Cereb Blood Flow Metab 2021;41:1778-90. [PMID: 33444091 DOI: 10.1177/0271678X20980652] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
98 Martinez AE, Weissberger G, Kuklenyik Z, He X, Meuret C, Parekh T, Rees JC, Parks BA, Gardner MS, King SM, Collier TS, Harrington MG, Sweeney MD, Wang X, Zlokovic BV, Joe E, Nation DA, Schneider LS, Chui HC, Barr JR, Han SD, Krauss RM, Yassine HN. The small HDL particle hypothesis of Alzheimer's disease. Alzheimers Dement 2022. [PMID: 35416404 DOI: 10.1002/alz.12649] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Li W, Lo EH. Leaky memories: Impact of APOE4 on blood-brain barrier and dementia. J Cereb Blood Flow Metab 2020;40:1912-4. [PMID: 32600092 DOI: 10.1177/0271678X20938146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Weber RZ, Grönnert L, Mulders G, Maurer MA, Tackenberg C, Schwab ME, Rust R. Characterization of the Blood Brain Barrier Disruption in the Photothrombotic Stroke Model. Front Physiol 2020;11:586226. [PMID: 33262704 DOI: 10.3389/fphys.2020.586226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
101 Preininger MK, Kaufer D. Blood-Brain Barrier Dysfunction and Astrocyte Senescence as Reciprocal Drivers of Neuropathology in Aging. Int J Mol Sci 2022;23:6217. [PMID: 35682895 DOI: 10.3390/ijms23116217] [Reference Citation Analysis]
102 De Kort AM, Kuiperij HB, Kersten I, Versleijen AAM, Schreuder FHBM, Van Nostrand WE, Greenberg SM, Klijn CJM, Claassen JAHR, Verbeek MM. Normal cerebrospinal fluid concentrations of PDGFRβ in patients with cerebral amyloid angiopathy and Alzheimer's disease. Alzheimers Dement 2021. [PMID: 34874603 DOI: 10.1002/alz.12506] [Reference Citation Analysis]
103 Ojo JO, Reed JM, Crynen G, Vallabhaneni P, Evans J, Shackleton B, Eisenbaum M, Ringland C, Edsell A, Mullan M, Crawford F, Bachmeier C. APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer's disease and age-matched non-demented brains. Mol Brain 2021;14:110. [PMID: 34238312 DOI: 10.1186/s13041-021-00803-9] [Reference Citation Analysis]
104 Hayley S, Hakim AM, Albert PR. Depression, dementia and immune dysregulation. Brain 2021;144:746-60. [PMID: 33279966 DOI: 10.1093/brain/awaa405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
105 Madsen LS, Nielsen RB, Parbo P, Ismail R, Mikkelsen IK, Gottrup H, Østergaard L, Brooks DJ, Eskildsen SF. Capillary function progressively deteriorates in prodromal Alzheimer’s disease: A longitudinal MRI perfusion study. Aging Brain 2022;2:100035. [DOI: 10.1016/j.nbas.2022.100035] [Reference Citation Analysis]
106 Tatulian SA. Challenges and hopes for Alzheimer's disease. Drug Discov Today 2022:S1359-6446(22)00038-1. [PMID: 35121174 DOI: 10.1016/j.drudis.2022.01.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
107 Johansen MC, Gottesman RF. Cerebrovascular Disease and Cognitive Outcome in Patients with Cardiac Disease. Semin Neurol 2021;41:463-72. [PMID: 33851395 DOI: 10.1055/s-0041-1726330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Liu S, Gao J, Liu K, Zhang HL. Microbiota-gut-brain axis and Alzheimer's disease: Implications of the blood-brain barrier as an intervention target. Mech Ageing Dev 2021;199:111560. [PMID: 34411603 DOI: 10.1016/j.mad.2021.111560] [Reference Citation Analysis]
109 Kerkhofs D, Wong SM, Zhang E, Uiterwijk R, Hoff EI, Jansen JFA, Staals J, Backes WH, van Oostenbrugge RJ. Blood-brain barrier leakage at baseline and cognitive decline in cerebral small vessel disease: a 2-year follow-up study. Geroscience 2021. [PMID: 34160780 DOI: 10.1007/s11357-021-00399-x] [Reference Citation Analysis]
110 Uchida K. Waste Clearance in the Brain and Neuroinflammation: A Novel Perspective on Biomarker and Drug Target Discovery in Alzheimer's Disease. Cells 2022;11:919. [PMID: 35269541 DOI: 10.3390/cells11050919] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
111 Chang Wong E, Chang Chui H. Vascular Cognitive Impairment and Dementia. Continuum (Minneap Minn) 2022;28:750-80. [PMID: 35678401 DOI: 10.1212/CON.0000000000001124] [Reference Citation Analysis]
112 Wang C, Xiong M, Gratuze M, Bao X, Shi Y, Andhey PS, Manis M, Schroeder C, Yin Z, Madore C, Butovsky O, Artyomov M, Ulrich JD, Holtzman DM. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron 2021;109:1657-1674.e7. [PMID: 33831349 DOI: 10.1016/j.neuron.2021.03.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
113 López-Otín C, Kroemer G. Hallmarks of Health. Cell 2021;184:33-63. [PMID: 33340459 DOI: 10.1016/j.cell.2020.11.034] [Cited by in Crossref: 37] [Cited by in F6Publishing: 45] [Article Influence: 18.5] [Reference Citation Analysis]
114 Lim YY, Pase MP, Buckley RF, Yassi N, Bransby L, Fowler C, Laws SM, Masters CL, Maruff P. Visual Memory Deficits in Middle-Aged APOE ɛ4 Homozygotes Detected Using Unsupervised Cognitive Assessments. JAD 2021;79:1563-73. [DOI: 10.3233/jad-201281] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Michinaga S, Koyama Y. Pathophysiological Responses and Roles of Astrocytes in Traumatic Brain Injury. Int J Mol Sci 2021;22:6418. [PMID: 34203960 DOI: 10.3390/ijms22126418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Theoharides TC. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Mol Neurobiol 2022. [PMID: 35028901 DOI: 10.1007/s12035-021-02696-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
117 Kurki SN, Kantonen J, Kaivola K, Hokkanen L, Mäyränpää MI, Puttonen H, Martola J, Pöyhönen M, Kero M, Tuimala J, Carpén O, Kantele A, Vapalahti O, Tiainen M, Tienari PJ, Kaila K, Hästbacka J, Myllykangas L; FinnGen. APOE ε4 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: a Finnish biobank, autopsy and clinical study. Acta Neuropathol Commun 2021;9:199. [PMID: 34949230 DOI: 10.1186/s40478-021-01302-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
118 Wang H, Lv JJ, Zhao Y, Wei HL, Zhang TJ, Yang HJ, Chen ZN, Jiang JL. Endothelial genetic deletion of CD147 induces changes in the dual function of the blood-brain barrier and is implicated in Alzheimer's disease. CNS Neurosci Ther 2021. [PMID: 33987940 DOI: 10.1111/cns.13659] [Reference Citation Analysis]
119 Khasanova DR, Zhitkova YV, Vaskaeva GR. Post-covid syndrome: a review of pathophysiology, neuropsychiatric manifestations and treatment perspectives. RJTAO 2021;13:93-8. [DOI: 10.14412/2074-2711-2021-3-93-98] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
120 Wang HL, Zhang CL, Qiu YM, Chen AQ, Li YN, Hu B. Dysfunction of the Blood-brain Barrier in Cerebral Microbleeds: from Bedside to Bench. Aging Dis 2021;12:1898-919. [PMID: 34881076 DOI: 10.14336/AD.2021.0514] [Reference Citation Analysis]
121 Qiao S, Shang K, Chu Y, Yu H, Chen X, Qin C, Pan D, Tian D, Zeng X. Apolipoprotein E ε4 Polymorphism as a Risk Factor for Ischemic Stroke: A Systematic Review and Meta-Analysis. Disease Markers 2022;2022:1-30. [DOI: 10.1155/2022/1407183] [Reference Citation Analysis]
122 Fraser MA, Walsh EI, Shaw ME, Anstey KJ, Cherbuin N. Longitudinal Effects of Physical Activity Change on Hippocampal Volumes over up to 12 Years in Middle and Older Age Community-Dwelling Individuals. Cereb Cortex 2021:bhab375. [PMID: 34671805 DOI: 10.1093/cercor/bhab375] [Reference Citation Analysis]
123 Lim B, Prassas I, Diamandis EP. From the amyloid hypothesis to the autoimmune hypothesis of Alzheimer's disease. Diagnosis (Berl) 2021. [PMID: 34496166 DOI: 10.1515/dx-2021-0108] [Reference Citation Analysis]
124 Hussain B, Fang C, Chang J. Blood–Brain Barrier Breakdown: An Emerging Biomarker of Cognitive Impairment in Normal Aging and Dementia. Front Neurosci 2021;15:688090. [DOI: 10.3389/fnins.2021.688090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
125 Sepehrband F, Barisano G, Sheikh-Bahaei N, Choupan J, Cabeen RP, Lynch KM, Crawford MS, Lan H, Mack WJ, Chui HC, Ringman JM, Toga AW; Alzheimer’s Disease Neuroimaging Initiative. Volumetric distribution of perivascular space in relation to mild cognitive impairment. Neurobiol Aging 2021;99:28-43. [PMID: 33422892 DOI: 10.1016/j.neurobiolaging.2020.12.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Ruiz-López E, Schuhmacher AJ. Transportation of Single-Domain Antibodies through the Blood-Brain Barrier. Biomolecules 2021;11:1131. [PMID: 34439797 DOI: 10.3390/biom11081131] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Klostranec JM, Vucevic D, Bhatia KD, Kortman HGJ, Krings T, Murphy KP, terBrugge KG, Mikulis DJ. Current Concepts in Intracranial Interstitial Fluid Transport and the Glymphatic System: Part II-Imaging Techniques and Clinical Applications. Radiology 2021;301:516-32. [PMID: 34698564 DOI: 10.1148/radiol.2021204088] [Reference Citation Analysis]
128 Huuskonen MT, Kisler K, Sagare AP, Zlokovic BV. On the intersection between systemic infection, brain vascular dysfunction and dementia. Brain 2021;144:1629-31. [PMID: 33974045 DOI: 10.1093/brain/awab168] [Reference Citation Analysis]
129 Sriram S, Mehkri Y, Quintin S, Lucke-wold B. Shared pathophysiology: Understanding stroke and Alzheimer’s disease. Clinical Neurology and Neurosurgery 2022;218:107306. [DOI: 10.1016/j.clineuro.2022.107306] [Reference Citation Analysis]
130 Itzhaki RF. Overwhelming Evidence for a Major Role for Herpes Simplex Virus Type 1 (HSV1) in Alzheimer's Disease (AD); Underwhelming Evidence against. Vaccines (Basel) 2021;9:679. [PMID: 34205498 DOI: 10.3390/vaccines9060679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
131 Van Etten EJ, Bharadwaj PK, Hishaw GA, Huentelman MJ, Trouard TP, Grilli MD, Alexander GE. Influence of regional white matter hyperintensity volume and apolipoprotein E ε4 status on hippocampal volume in healthy older adults. Hippocampus 2021;31:469-80. [PMID: 33586848 DOI: 10.1002/hipo.23308] [Reference Citation Analysis]
132 Bicker J, Alves G, Fonseca C, Falcão A, Fortuna A. Repairing blood-CNS barriers: Future therapeutic approaches for neuropsychiatric disorders. Pharmacol Res 2020;162:105226. [PMID: 33007420 DOI: 10.1016/j.phrs.2020.105226] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
133 Li J, Zheng M, Shimoni O, Banks WA, Bush AI, Gamble JR, Shi B. Development of Novel Therapeutics Targeting the Blood-Brain Barrier: From Barrier to Carrier. Adv Sci (Weinh) 2021;8:e2101090. [PMID: 34085418 DOI: 10.1002/advs.202101090] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
134 Liang T, Hang W, Chen J, Wu Y, Wen B, Xu K, Ding B, Chen J. ApoE4 (Δ272-299) induces mitochondrial-associated membrane formation and mitochondrial impairment by enhancing GRP75-modulated mitochondrial calcium overload in neuron. Cell Biosci 2021;11:50. [PMID: 33676568 DOI: 10.1186/s13578-021-00563-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
135 Zhao Q, Dai W, Chen HY, Jacobs RE, Zlokovic BV, Lund BT, Montagne A, Bonnin A. Prenatal disruption of blood-brain barrier formation via cyclooxygenase activation leads to lifelong brain inflammation. Proc Natl Acad Sci U S A 2022;119:e2113310119. [PMID: 35377817 DOI: 10.1073/pnas.2113310119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
136 Montagne A, Barnes SR, Nation DA, Kisler K, Toga AW, Zlokovic BV. Imaging subtle leaks in the blood-brain barrier in the aging human brain: potential pitfalls, challenges, and possible solutions. Geroscience 2022. [PMID: 35469116 DOI: 10.1007/s11357-022-00571-x] [Reference Citation Analysis]
137 Chagnot A, Barnes SR, Montagne A. Magnetic Resonance Imaging of Blood-Brain Barrier permeability in Dementia. Neuroscience 2021;474:14-29. [PMID: 34400249 DOI: 10.1016/j.neuroscience.2021.08.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Proshkina EN, Solovev IA, Shaposhnikov MV, Moskalev AA. Key Molecular Mechanisms of Aging, Biomarkers, and Potential Interventions. Mol Biol 2020;54:777-811. [DOI: 10.1134/s0026893320060096] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
139 Yang Q, Wei X, Deng B, Chang Z, Jin D, Huang Y, Zhang JH, Yenari MA, Jin K, Wang Q. Cerebral small vessel disease alters neurovascular unit regulation of microcirculation integrity involved in vascular cognitive impairment. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105750] [Reference Citation Analysis]
140 Erickson MA, Banks WA. Transcellular routes of blood-brain barrier disruption. Exp Biol Med (Maywood) 2022;:15353702221080745. [PMID: 35243912 DOI: 10.1177/15353702221080745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
141 Virtuoso A, Colangelo AM, Maggio N, Fennig U, Weinberg N, Papa M, De Luca C. The Spatiotemporal Coupling: Regional Energy Failure and Aberrant Proteins in Neurodegenerative Diseases. Int J Mol Sci 2021;22:11304. [PMID: 34768733 DOI: 10.3390/ijms222111304] [Reference Citation Analysis]
142 Zhang Z, Na H, Gan Q, Tao Q, Alekseyev Y, Hu J, Yan Z, Yang JB, Tian H, Zhu S, Li Q, Rajab IM, Blusztajn JK, Wolozin B, Emili A, Zhang X, Stein T, Potempa LA, Qiu WQ. Monomeric C-reactive protein via endothelial CD31 for neurovascular inflammation in an ApoE genotype-dependent pattern: A risk factor for Alzheimer's disease? Aging Cell 2021;20:e13501. [PMID: 34687487 DOI: 10.1111/acel.13501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
143 Anderson KE, Bellio TA, Aniskovich E, Adams SL, Blusztajn JK, Delalle I. The Expression of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) in Hippocampal Arterioles Declines During Progression of Alzheimer's Disease. Cereb Cortex Commun 2020;1:tgaa031. [PMID: 32974611 DOI: 10.1093/texcom/tgaa031] [Reference Citation Analysis]
144 Ribovski L, Hamelmann NM, Paulusse JMJ. Polymeric Nanoparticles Properties and Brain Delivery. Pharmaceutics 2021;13:2045. [PMID: 34959326 DOI: 10.3390/pharmaceutics13122045] [Reference Citation Analysis]
145 Janigro D, Bailey DM, Lehmann S, Badaut J, O'Flynn R, Hirtz C, Marchi N. Peripheral Blood and Salivary Biomarkers of Blood-Brain Barrier Permeability and Neuronal Damage: Clinical and Applied Concepts. Front Neurol 2020;11:577312. [PMID: 33613412 DOI: 10.3389/fneur.2020.577312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Nehra G, Bauer B, Hartz AMS. Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance. Pharmacol Ther 2022;234:108119. [PMID: 35108575 DOI: 10.1016/j.pharmthera.2022.108119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
147 Smith BC, Tinkey RA, Shaw BC, Williams JL. Targetability of the neurovascular unit in inflammatory diseases of the central nervous system. Immunol Rev 2022. [PMID: 35909222 DOI: 10.1111/imr.13121] [Reference Citation Analysis]
148 Parodi-Rullán RM, Javadov S, Fossati S. Dissecting the Crosstalk between Endothelial Mitochondrial Damage, Vascular Inflammation, and Neurodegeneration in Cerebral Amyloid Angiopathy and Alzheimer's Disease. Cells 2021;10:2903. [PMID: 34831125 DOI: 10.3390/cells10112903] [Reference Citation Analysis]
149 Lloret A, Esteve D, Lloret MA, Monllor P, López B, León JL, Cervera-Ferri A. Is Oxidative Stress the Link Between Cerebral Small Vessel Disease, Sleep Disruption, and Oligodendrocyte Dysfunction in the Onset of Alzheimer's Disease? Front Physiol 2021;12:708061. [PMID: 34512381 DOI: 10.3389/fphys.2021.708061] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Imbimbo BP, Lozupone M, Watling M, Panza F. Discontinued disease-modifying therapies for Alzheimer's disease: status and future perspectives. Expert Opin Investig Drugs 2020;29:919-33. [PMID: 32657175 DOI: 10.1080/13543784.2020.1795127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
151 Zhou C, Bei J, Qiu Y, Chang Q, Nyong E, Vasilakis N, Yang J, Krishnan B, Khanipov K, Jin Y, Fang X, Gaitas A, Gong B. Exosomally Targeting microRNA23a Ameliorates Microvascular Endothelial Barrier Dysfunction Following Rickettsial Infection. Front Immunol 2022;13:904679. [DOI: 10.3389/fimmu.2022.904679] [Reference Citation Analysis]
152 Yim Y, Choi JD, Cho JH, Moon Y, Han SH, Moon WJ. Magnetic susceptibility in the deep gray matter may be modulated by apolipoprotein E4 and age with regional predilections: a quantitative susceptibility mapping study. Neuroradiology 2022. [PMID: 34981175 DOI: 10.1007/s00234-021-02859-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
153 Albrecht D, Isenberg AL, Stradford J, Monreal T, Sagare A, Pachicano M, Sweeney M, Toga A, Zlokovic B, Chui H, Joe E, Schneider L, Conti P, Jann K, Pa J. Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid. J Neurosci 2020;40:8573-86. [PMID: 33046556 DOI: 10.1523/JNEUROSCI.1230-20.2020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
154 Girolamo F, Errede M, Bizzoca A, Virgintino D, Ribatti D. Central Nervous System Pericytes Contribute to Health and Disease. Cells 2022;11:1707. [DOI: 10.3390/cells11101707] [Reference Citation Analysis]
155 Erickson MA, Rhea EM, Knopp RC, Banks WA. Interactions of SARS-CoV-2 with the Blood-Brain Barrier. Int J Mol Sci 2021;22:2681. [PMID: 33800954 DOI: 10.3390/ijms22052681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
156 Eide PK, Mariussen E, Uggerud H, Pripp AH, Lashkarivand A, Hassel B, Christensen H, Hovd MH, Ringstad G. Clinical application of intrathecal gadobutrol for assessment of cerebrospinal fluid tracer clearance to blood. JCI Insight 2021;6:147063. [PMID: 33822769 DOI: 10.1172/jci.insight.147063] [Reference Citation Analysis]
157 Li Y, Zhang J, Wan J, Liu A, Sun J. Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer's disease. Biomed Pharmacother 2020;132:110887. [PMID: 33254429 DOI: 10.1016/j.biopha.2020.110887] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
158 Moon WJ, Lim C, Ha IH, Kim Y, Moon Y, Kim HJ, Han SH. Hippocampal blood-brain barrier permeability is related to the APOE4 mutation status of elderly individuals without dementia. J Cereb Blood Flow Metab 2021;41:1351-61. [PMID: 32936729 DOI: 10.1177/0271678X20952012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
159 Sierksma A, Escott-price V, De Strooper B. Translating genetic risk of Alzheimer’s disease into mechanistic insight and drug targets. Science 2020;370:61-6. [DOI: 10.1126/science.abb8575] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
160 Chai AB, Lam HHJ, Kockx M, Gelissen IC. Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158980. [PMID: 34044125 DOI: 10.1016/j.bbalip.2021.158980] [Reference Citation Analysis]
161 Huuskonen MT, Liu Q, Lamorie-Foote K, Shkirkova K, Connor M, Patel A, Montagne A, Baertsch H, Sioutas C, Morgan TE, Finch CE, Zlokovic BV, Mack WJ. Air Pollution Particulate Matter Amplifies White Matter Vascular Pathology and Demyelination Caused by Hypoperfusion. Front Immunol 2021;12:785519. [PMID: 34868068 DOI: 10.3389/fimmu.2021.785519] [Reference Citation Analysis]
162 Clouston SAP, Hall CB, Kritikos M, Bennett DA, DeKosky S, Edwards J, Finch C, Kreisl WC, Mielke M, Peskind ER, Raskind M, Richards M, Sloan RP, Spiro A 3rd, Vasdev N, Brackbill R, Farfel M, Horton M, Lowe S, Lucchini RG, Prezant D, Reibman J, Rosen R, Seil K, Zeig-Owens R, Deri Y, Diminich ED, Fausto BA, Gandy S, Sano M, Bromet EJ, Luft BJ. Cognitive impairment and World Trade Centre-related exposures. Nat Rev Neurol 2021. [PMID: 34795448 DOI: 10.1038/s41582-021-00576-8] [Reference Citation Analysis]
163 Zhang Q, Xie C. Apolipoprotein E Drives Early Blood-Brain Barrier Damage in Alzheimer's Disease. Neurosci Bull 2021;37:281-3. [PMID: 33068281 DOI: 10.1007/s12264-020-00596-2] [Reference Citation Analysis]
164 Olsen I. Possible effects of Porphyromonas gingivalis on the blood-brain barrier in Alzheimer's disease. Expert Rev Anti Infect Ther 2021;:1-5. [PMID: 33938372 DOI: 10.1080/14787210.2021.1925540] [Reference Citation Analysis]
165 Walker RM, Vaher K, Bermingham ML, Morris SW, Bretherick AD, Zeng Y, Rawlik K, Amador C, Campbell A, Haley CS, Hayward C, Porteous DJ, McIntosh AM, Marioni RE, Evans KL. Identification of epigenome-wide DNA methylation differences between carriers of APOE ε4 and APOE ε2 alleles. Genome Med 2021;13:1. [PMID: 33397400 DOI: 10.1186/s13073-020-00808-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Propson NE, Roy ER, Litvinchuk A, Köhl J, Zheng H. Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging. J Clin Invest 2021;131:140966. [PMID: 32990682 DOI: 10.1172/JCI140966] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
167 Nir TM, Haddad E, Thompson PM, Jahanshad N. Neuroimaging Advances in Diagnosis and Differentiation of HIV, Comorbidities, and Aging in the cART Era. Curr Top Behav Neurosci 2021. [PMID: 33782916 DOI: 10.1007/7854_2021_221] [Reference Citation Analysis]
168 Evans P, Wojta J, Hoefer IE, Waltenberger J, Guzik T, Badimon L, Weber C. The year in basic vascular biology research: from mechanoreceptors and neutrophil extracellular traps to smartphone data and omics. Cardiovasc Res 2021;117:1814-22. [PMID: 33744925 DOI: 10.1093/cvr/cvab105] [Reference Citation Analysis]
169 Kim TA, Chen L, Ge S. The interplay of neurovasculature and adult hippocampal neurogenesis. Neurosci Lett 2021;760:136071. [PMID: 34147540 DOI: 10.1016/j.neulet.2021.136071] [Reference Citation Analysis]
170 Löscher W, Howe CL. Molecular Mechanisms in the Genesis of Seizures and Epilepsy Associated With Viral Infection. Front Mol Neurosci 2022;15:870868. [DOI: 10.3389/fnmol.2022.870868] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Natunen T, Martiskainen H, Marttinen M, Gabbouj S, Koivisto H, Kemppainen S, Kaipainen S, Takalo M, Svobodová H, Leppänen L, Kemiläinen B, Ryhänen S, Kuulasmaa T, Rahunen E, Juutinen S, Mäkinen P, Miettinen P, Rauramaa T, Pihlajamäki J, Haapasalo A, Leinonen V, Tanila H, Hiltunen M. Diabetic phenotype in mouse and humans reduces the number of microglia around β-amyloid plaques. Mol Neurodegener 2020;15:66. [PMID: 33168021 DOI: 10.1186/s13024-020-00415-2] [Reference Citation Analysis]
172 Chen Z, Schwulst SJ, Mentis AA. APOE4-mediated Alzheimer disease and "Vascular"-"Meningeal Lymphatic" components: towards a novel therapeutic era? Mol Psychiatry 2021. [PMID: 34376823 DOI: 10.1038/s41380-021-01242-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Winkler EA, Kim CN, Ross JM, Garcia JH, Gil E, Oh I, Chen LQ, Wu D, Catapano JS, Raygor K, Narsinh K, Kim H, Weinsheimer S, Cooke DL, Walcott BP, Lawton MT, Gupta N, Zlokovic BV, Chang EF, Abla AA, Lim DA, Nowakowski TJ. A single-cell atlas of the normal and malformed human brain vasculature. Science 2022;:eabi7377. [PMID: 35084939 DOI: 10.1126/science.abi7377] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 18.0] [Reference Citation Analysis]
174 Ciminelli BM, Menduti G, Benussi L, Ghidoni R, Binetti G, Squitti R, Rongioletti M, Nica S, Novelletto A, Rossi L, Malaspina P. Polymorphic Genetic Markers of the GABA Catabolism Pathway in Alzheimer's Disease. J Alzheimers Dis 2020;77:301-11. [PMID: 32804142 DOI: 10.3233/JAD-200429] [Reference Citation Analysis]
175 Collin BG, Raju D, Katsikas S. The cognitive effects of anticholinergic drugs on apolipoprotein ε4 carriers and noncarriers in the Wisconsin Registry for Alzheimer's Prevention study. Neuropsychology 2021;35:220-31. [PMID: 33764112 DOI: 10.1037/neu0000713] [Reference Citation Analysis]
176 Angiulli F, Conti E, Zoia CP, Da Re F, Appollonio I, Ferrarese C, Tremolizzo L. Blood-Based Biomarkers of Neuroinflammation in Alzheimer's Disease: A Central Role for Periphery? Diagnostics (Basel) 2021;11:1525. [PMID: 34573867 DOI: 10.3390/diagnostics11091525] [Reference Citation Analysis]
177 Mandelblatt JS, Ahles TA, Lippman ME, Isaacs C, Adams-Campbell L, Saykin AJ, Cohen HJ, Carroll J. Applying a Life Course Biological Age Framework to Improving the Care of Individuals With Adult Cancers: Review and Research Recommendations. JAMA Oncol 2021. [PMID: 34351358 DOI: 10.1001/jamaoncol.2021.1160] [Reference Citation Analysis]
178 Barnes S, Chowdhury S, Gatto NM, Fraser GE, Lee GJ. Omega-3 fatty acids are associated with blood-brain barrier integrity in a healthy aging population. Brain Behav 2021. [PMID: 34327870 DOI: 10.1002/brb3.2273] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
179 Ouk M, Wu CY, Rabin JS, Jackson A, Edwards JD, Ramirez J, Masellis M, Swartz RH, Herrmann N, Lanctôt KL, Black SE, Swardfager W. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status. Alzheimers Res Ther 2021;13:43. [PMID: 33573702 DOI: 10.1186/s13195-021-00778-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
180 Turri M, Marchi C, Adorni MP, Calabresi L, Zimetti F. Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders. Biochim Biophys Acta Mol Cell Biol Lipids 2022;:159123. [PMID: 35151900 DOI: 10.1016/j.bbalip.2022.159123] [Reference Citation Analysis]
181 van Olst L, Coenen L, Nieuwland JM, Rodriguez-Mogeda C, de Wit NM, Kamermans A, Middeldorp J, de Vries HE. Crossing borders in Alzheimer's disease: A T cell's perspective. Adv Drug Deliv Rev 2022;188:114398. [PMID: 35780907 DOI: 10.1016/j.addr.2022.114398] [Reference Citation Analysis]
182 Lin L, Wu Y, Chen Z, Huang L, Wang L, Liu L. Severe Hypoglycemia Contributing to Cognitive Dysfunction in Diabetic Mice Is Associated With Pericyte and Blood-Brain Barrier Dysfunction. Front Aging Neurosci 2021;13:775244. [PMID: 34899278 DOI: 10.3389/fnagi.2021.775244] [Reference Citation Analysis]
183 Banks WA, Rhea EM. The Blood-Brain Barrier, Oxidative Stress, and Insulin Resistance. Antioxidants (Basel) 2021;10:1695. [PMID: 34829566 DOI: 10.3390/antiox10111695] [Reference Citation Analysis]
184 Shinohara M, Kanekiyo T, Tachibana M, Kurti A, Shinohara M, Fu Y, Zhao J, Han X, Sullivan PM, Rebeck GW, Fryer JD, Heckman MG, Bu G. APOE2 is associated with longevity independent of Alzheimer's disease. Elife 2020;9:e62199. [PMID: 33074098 DOI: 10.7554/eLife.62199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
185 Seaks CE, Weekman EM, Sudduth TL, Xie K, Wasek B, Fardo DW, Johnson LA, Bottiglieri T, Wilcock DM. Apolipoprotein E ε4/4 genotype limits response to dietary induction of hyperhomocysteinemia and resulting inflammatory signaling. J Cereb Blood Flow Metab 2022;:271678X211069006. [PMID: 35023380 DOI: 10.1177/0271678X211069006] [Reference Citation Analysis]
186 Brown D, Altermatt M, Dobreva T, Chen S, Wang A, Thomson M, Gradinaru V. Deep Parallel Characterization of AAV Tropism and AAV-Mediated Transcriptional Changes via Single-Cell RNA Sequencing. Front Immunol 2021;12:730825. [PMID: 34759919 DOI: 10.3389/fimmu.2021.730825] [Reference Citation Analysis]
187 Sible IJ, Nation DA; Alzheimer’s Disease Neuroimaging Initiative. Blood pressure variability and medial temporal atrophy in apolipoprotein ϵ4 carriers. Brain Imaging Behav 2021. [PMID: 34581957 DOI: 10.1007/s11682-021-00553-1] [Reference Citation Analysis]
188 Timmers PRHJ, Tiys ES, Sakaue S, Akiyama M, Kiiskinen TTJ, Zhou W, Hwang S, Yao C, Kamatani Y, Zhou W, Deelen J, Levy D, Ganna A, Kamatani Y, Okada Y, Joshi PK, Wilson JF, Tsepilov YA; Biobank Japan Project, FinnGen. Mendelian randomization of genetically independent aging phenotypes identifies LPA and VCAM1 as biological targets for human aging. Nat Aging 2022;2:19-30. [DOI: 10.1038/s43587-021-00159-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
189 Litvinchuk A, Huynh TV, Shi Y, Jackson RJ, Finn MB, Manis M, Francis CM, Tran AC, Sullivan PM, Ulrich JD, Hyman BT, Cole T, Holtzman DM. Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model. Ann Neurol 2021;89:952-66. [PMID: 33550655 DOI: 10.1002/ana.26043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
190 Li Z, Shue F, Zhao N, Shinohara M, Bu G. APOE2: protective mechanism and therapeutic implications for Alzheimer's disease. Mol Neurodegener 2020;15:63. [PMID: 33148290 DOI: 10.1186/s13024-020-00413-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
191 Hofer E, Pirpamer L, Langkammer C, Tinauer C, Seshadri S, Schmidt H, Schmidt R. Heritability of R2* iron in the basal ganglia and cortex. Aging (Albany NY) 2022;14. [PMID: 35951362 DOI: 10.18632/aging.204212] [Reference Citation Analysis]
192 Marsillach J, Adorni MP, Zimetti F, Papotti B, Zuliani G, Cervellati C. HDL Proteome and Alzheimer's Disease: Evidence of a Link. Antioxidants (Basel) 2020;9:E1224. [PMID: 33287338 DOI: 10.3390/antiox9121224] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
193 Austad SN, Ballinger S, Buford TW, Carter CS, Smith DL Jr, Darley-Usmar V, Zhang J. Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease. Acta Pharm Sin B 2022;12:511-31. [PMID: 35256932 DOI: 10.1016/j.apsb.2021.06.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
194 Segura-Collar B, Mata-Martínez P, Hernández-Laín A, Sánchez-Gómez P, Gargini R. Blood-Brain Barrier Disruption: A Common Driver of Central Nervous System Diseases. Neuroscientist 2021;:1073858420985838. [PMID: 33446074 DOI: 10.1177/1073858420985838] [Reference Citation Analysis]
195 Ingala S, Mazzai L, Sudre CH, Salvadó G, Brugulat-Serrat A, Wottschel V, Falcon C, Operto G, Tijms B, Gispert JD, Molinuevo JL, Barkhof F; ALFA Study. The relation between APOE genotype and cerebral microbleeds in cognitively unimpaired middle- and old-aged individuals. Neurobiol Aging 2020;95:104-14. [PMID: 32791423 DOI: 10.1016/j.neurobiolaging.2020.06.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
196 Lozupone M, Solfrizzi V, D'Urso F, Di Gioia I, Sardone R, Dibello V, Stallone R, Liguori A, Ciritella C, Daniele A, Bellomo A, Seripa D, Panza F. Anti-amyloid-β protein agents for the treatment of Alzheimer's disease: an update on emerging drugs. Expert Opin Emerg Drugs 2020;25:319-35. [PMID: 32772738 DOI: 10.1080/14728214.2020.1808621] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
197 de Wit NM, Mol K, Rodríguez-Lorenzo S, de Vries HE, Kooij G. The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer's Disease. Front Immunol 2020;11:620348. [PMID: 33633739 DOI: 10.3389/fimmu.2020.620348] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
198 Liang X, Wu H, Colt M, Guo X, Pluimer B, Zeng J, Dong S, Zhao Z. Microglia and its genetics in Alzheimer's Disease. Curr Alzheimer Res 2021. [PMID: 34749609 DOI: 10.2174/1567205018666211105140732] [Reference Citation Analysis]
199 Korte N, Nortley R, Attwell D. Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease. Acta Neuropathol 2020;140:793-810. [PMID: 32865691 DOI: 10.1007/s00401-020-02215-w] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 25.0] [Reference Citation Analysis]
200 Custodia A, Ouro A, Romaus-sanjurjo D, Pías-peleteiro JM, de Vries HE, Castillo J, Sobrino T. Endothelial Progenitor Cells and Vascular Alterations in Alzheimer’s Disease. Front Aging Neurosci 2022;13:811210. [DOI: 10.3389/fnagi.2021.811210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
201 Arakaki X, Hung S, Rochart R, Fonteh AN, Harrington MG. Alpha desynchronization during Stroop test unmasks cognitively healthy individuals with abnormal CSF Amyloid/Tau. Neurobiology of Aging 2022;112:87-101. [DOI: 10.1016/j.neurobiolaging.2021.11.009] [Reference Citation Analysis]
202 Wang J, Fan DY, Li HY, He CY, Shen YY, Zeng GH, Chen DW, Yi X, Ma YH, Yu JT, Wang YJ. Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers. Mol Neurodegener 2022;17:9. [PMID: 35033164 DOI: 10.1186/s13024-021-00512-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
203 Miners S, Kehoe PG, Love S. Cognitive impact of COVID-19: looking beyond the short term. Alzheimers Res Ther 2020;12:170. [PMID: 33380345 DOI: 10.1186/s13195-020-00744-w] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
204 Kritikos M, Gandy SE, Meliker JR, Luft BJ, Clouston SAP. Acute versus Chronic Exposures to Inhaled Particulate Matter and Neurocognitive Dysfunction: Pathways to Alzheimer's Disease or a Related Dementia. J Alzheimers Dis 2020;78:871-86. [PMID: 33074229 DOI: 10.3233/JAD-200679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
205 Bennett HC, Kim Y. Pericytes Across the Lifetime in the Central Nervous System. Front Cell Neurosci 2021;15:627291. [PMID: 33776651 DOI: 10.3389/fncel.2021.627291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
206 Manning C, Stringer M, Dickie B, Clancy U, Valdés Hernandez MC, Wiseman SJ, Garcia DJ, Sakka E, Backes WH, Ingrisch M, Chappell F, Doubal F, Buckley C, Parkes LM, Parker GJM, Marshall I, Wardlaw JM, Thrippleton MJ. Sources of systematic error in DCE-MRI estimation of low-level blood-brain barrier leakage. Magn Reson Med 2021;86:1888-903. [PMID: 34002894 DOI: 10.1002/mrm.28833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Fernandez HR, Varma A, Flowers SA, Rebeck GW. Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer's Disease Risk Factor APOE. Cancers (Basel) 2020;12:E3842. [PMID: 33352780 DOI: 10.3390/cancers12123842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
208 Hovd MH, Mariussen E, Uggerud H, Lashkarivand A, Christensen H, Ringstad G, Eide PK. Population pharmacokinetic modeling of CSF to blood clearance: prospective tracer study of 161 patients under work-up for CSF disorders. Fluids Barriers CNS 2022;19:55. [PMID: 35778719 DOI: 10.1186/s12987-022-00352-w] [Reference Citation Analysis]
209 Da Mesquita S, Papadopoulos Z, Dykstra T, Brase L, Farias FG, Wall M, Jiang H, Kodira CD, de Lima KA, Herz J, Louveau A, Goldman DH, Salvador AF, Onengut-Gumuscu S, Farber E, Dabhi N, Kennedy T, Milam MG, Baker W, Smirnov I, Rich SS, Benitez BA, Karch CM, Perrin RJ, Farlow M, Chhatwal JP, Holtzman DM, Cruchaga C, Harari O, Kipnis J; Dominantly Inherited Alzheimer Network. Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy. Nature 2021;593:255-60. [PMID: 33911285 DOI: 10.1038/s41586-021-03489-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
210 Fisher RA, Miners JS, Love S. Pathological changes within the cerebral vasculature in Alzheimer's disease: New perspectives. Brain Pathol 2022;:e13061. [PMID: 35289012 DOI: 10.1111/bpa.13061] [Reference Citation Analysis]
211 Melgarejo JD, Aguirre-Acevedo DC, Gaona C, Chavez CA, Calmón GE, Silva ER, de Erausquin GA, Gil M, Mena LJ, Terwilliger JD, Arboleda H, Scarmeas N, Lee JH, Maestre GE. Nighttime Blood Pressure Interacts with APOE Genotype to Increase the Risk of Incident Dementia of the Alzheimer's Type in Hispanics. J Alzheimers Dis 2020;77:569-79. [PMID: 32675415 DOI: 10.3233/JAD-200430] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
212 Nelson AR. Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease. Front Aging Neurosci 2022;14:858429. [DOI: 10.3389/fnagi.2022.858429] [Reference Citation Analysis]
213 Umeh CC, Mahajan A, Mihailovic A, Pontone GM. APOE4 Allele, Sex, and Dementia Risk in Parkinson’s Disease: Lessons From a Longitudinal Cohort. J Geriatr Psychiatry Neurol. [DOI: 10.1177/08919887211060019] [Reference Citation Analysis]
214 Hawksworth J, Fernández E, Gevaert K. A new generation of AD biomarkers: 2019 to 2021. Ageing Res Rev 2022;79:101654. [PMID: 35636691 DOI: 10.1016/j.arr.2022.101654] [Reference Citation Analysis]
215 Topiwala A, Ebmeier KP, Maullin-Sapey T, Nichols TE. Alcohol consumption and MRI markers of brain structure and function: Cohort study of 25,378 UK Biobank participants. Neuroimage Clin 2022;35:103066. [PMID: 35653911 DOI: 10.1016/j.nicl.2022.103066] [Reference Citation Analysis]
216 Pivoriūnas A, Verkhratsky A. Astrocyte-Endotheliocyte Axis in the Regulation of the Blood-Brain Barrier. Neurochem Res 2021. [PMID: 33961207 DOI: 10.1007/s11064-021-03338-6] [Reference Citation Analysis]
217 Lin Z, Sur S, Liu P, Li Y, Jiang D, Hou X, Darrow J, Pillai JJ, Yasar S, Rosenberg P, Albert M, Moghekar A, Lu H. Blood-Brain Barrier Breakdown in Relationship to Alzheimer and Vascular Disease. Ann Neurol 2021;90:227-38. [PMID: 34041783 DOI: 10.1002/ana.26134] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
218 Mahaman YAR, Embaye KS, Huang F, Li L, Zhu F, Wang JZ, Liu R, Feng J, Wang X. Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention. Ageing Res Rev 2022;74:101544. [PMID: 34933129 DOI: 10.1016/j.arr.2021.101544] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
219 Xue R, Chen M, Cai J, Deng Z, Pan D, Liu X, Li Y, Rong X, Li H, Xu Y, Shen Q, Tang Y. Blood-Brain Barrier Repair of Bevacizumab and Corticosteroid as Prediction of Clinical Improvement and Relapse Risk in Radiation-Induced Brain Necrosis: A Retrospective Observational Study. Front Oncol 2021;11:720417. [PMID: 34692494 DOI: 10.3389/fonc.2021.720417] [Reference Citation Analysis]
220 Manzo C, Serra-Mestres J, Isetta M, Castagna A. Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4? Med Hypotheses 2021;147:110479. [PMID: 33422806 DOI: 10.1016/j.mehy.2020.110479] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
221 Bondareva O, Sheikh BN. Vascular Homeostasis and Inflammation in Health and Disease-Lessons from Single Cell Technologies. Int J Mol Sci 2020;21:E4688. [PMID: 32630148 DOI: 10.3390/ijms21134688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
222 Yang W, Bai X, Luan X, Min J, Tian X, Li H, Li H, Sun W, Liu W, Fan W, Liu W, Sun L. Delicate regulation of IL-1β-mediated inflammation by cyclophilin A. Cell Rep 2022;38:110513. [PMID: 35294882 DOI: 10.1016/j.celrep.2022.110513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
223 Memel M, Staffaroni AM, Cobigo Y, Casaletto KB, Fonseca C, Bettcher BM, Yassa MA, Elahi FM, Wolf A, Rosen HJ, Kramer JH. APOE moderates the effect of hippocampal blood flow on memory pattern separation in clinically normal older adults. Hippocampus 2021;31:845-57. [PMID: 33835624 DOI: 10.1002/hipo.23327] [Reference Citation Analysis]
224 Yan Y, Gao Y, Fang Q, Zhang N, Kumar G, Yan H, Song L, Li J, Zhang Y, Sun J, Wang J, Zhao L, Skaggs K, Zhang HT, Ma CG. Inhibition of Rho Kinase by Fasudil Ameliorates Cognition Impairment in APP/PS1 Transgenic Mice via Modulation of Gut Microbiota and Metabolites. Front Aging Neurosci 2021;13:755164. [PMID: 34721000 DOI: 10.3389/fnagi.2021.755164] [Reference Citation Analysis]
225 Kasparian K, Graykowski D, Cudaback E. Commentary: APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort. Front Immunol 2020;11:1939. [PMID: 33042114 DOI: 10.3389/fimmu.2020.01939] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
226 Li L, Yang Y, Zhang Q, Wang J, Jiang J, Neuroimaging Initiative AD. Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer's Disease or Mild Cognitive Impairment. Behav Neurol 2021;2021:3359103. [PMID: 34336000 DOI: 10.1155/2021/3359103] [Reference Citation Analysis]
227 Michalicova A, Majerova P, Kovac A. Tau Protein and Its Role in Blood-Brain Barrier Dysfunction. Front Mol Neurosci 2020;13:570045. [PMID: 33100967 DOI: 10.3389/fnmol.2020.570045] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
228 Duro MV, Ebright B, Yassine HN. Lipids and brain inflammation in APOE4-associated dementia. Curr Opin Lipidol 2022;33:16-24. [PMID: 34907965 DOI: 10.1097/MOL.0000000000000801] [Reference Citation Analysis]
229 Verheggen ICM, de Jong JJA, van Boxtel MPJ, Postma AA, Jansen JFA, Verhey FRJ, Backes WH. Imaging the role of blood-brain barrier disruption in normal cognitive ageing. Geroscience 2020;42:1751-64. [PMID: 33025410 DOI: 10.1007/s11357-020-00282-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
230 Preman P, Alfonso-Triguero M, Alberdi E, Verkhratsky A, Arranz AM. Astrocytes in Alzheimer's Disease: Pathological Significance and Molecular Pathways. Cells 2021;10:540. [PMID: 33806259 DOI: 10.3390/cells10030540] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
231 Takechi R, Mamo J, Das S, Graneri L, D'Alonzo Z, Nesbit M, Junaldi E, Lam V. Short-term consumption of alcohol (vodka) mixed with energy drink (AMED) attenuated alcohol-induced cerebral capillary disturbances and neuroinflammation in adult wild-type mice. Nutr Neurosci 2021;:1-10. [PMID: 34549671 DOI: 10.1080/1028415X.2021.1975364] [Reference Citation Analysis]
232 Sanchez-Cano F, Hernández-Kelly LC, Ortega A. The Blood-Brain Barrier: Much More Than a Selective Access to the Brain. Neurotox Res 2021;39:2154-74. [PMID: 34677787 DOI: 10.1007/s12640-021-00431-0] [Reference Citation Analysis]
233 Moon Y, Lim C, Kim Y, Moon WJ. Sex-Related Differences in Regional Blood-Brain Barrier Integrity in Non-Demented Elderly Subjects. Int J Mol Sci 2021;22:2860. [PMID: 33799794 DOI: 10.3390/ijms22062860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
234 Dulewicz M, Kulczyńska-Przybik A, Słowik A, Borawska R, Mroczko B. Fatty Acid Binding Protein 3 (FABP3) and Apolipoprotein E4 (ApoE4) as Lipid Metabolism-Related Biomarkers of Alzheimer's Disease. J Clin Med 2021;10:3009. [PMID: 34300173 DOI: 10.3390/jcm10143009] [Reference Citation Analysis]
235 Loika Y, Feng F, Loiko E, Kulminski AM. Mediation of the APOE associations with Alzheimer's and coronary heart diseases through body mass index and lipids. Geroscience 2021. [PMID: 34554385 DOI: 10.1007/s11357-021-00458-3] [Reference Citation Analysis]
236 Bai H, Kaur H, Kallianpur AR, Hulgan T, Franklin DR Jr, Letendre SL, Ellis RJ, Bush WS. A Haptoglobin Exon Copy Number Variant Associates With HIV-Associated Neurocognitive Impairment in European and African-Descent Populations. Front Genet 2021;12:756685. [PMID: 35003209 DOI: 10.3389/fgene.2021.756685] [Reference Citation Analysis]
237 Ma Y, Sajeev G, VanderWeele TJ, Viswanathan A, Sigurdsson S, Eiriksdottir G, Aspelund T, Betensky RA, Grodstein F, Hofman A, Gudnason V, Launer L, Blacker D. APOE ε4 and late-life cognition: mediation by structural brain imaging markers. Eur J Epidemiol 2022. [PMID: 35471691 DOI: 10.1007/s10654-022-00864-7] [Reference Citation Analysis]
238 Roussarie JP, Rodriguez-Rodriguez P. Deciphering cell-type specific signal transduction in the brain: Challenges and promises. Adv Pharmacol 2021;90:145-71. [PMID: 33706931 DOI: 10.1016/bs.apha.2020.09.009] [Reference Citation Analysis]
239 Storck SE, Hartz AMS, Pietrzik CU. The Blood-Brain Barrier in Alzheimer's Disease. Handb Exp Pharmacol 2021. [PMID: 33580390 DOI: 10.1007/164_2020_418] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
240 Roseborough AD, Rasheed B, Jung Y, Nishimura K, Pinsky W, Langdon KD, Hammond R, Pasternak SH, Khan AR, Whitehead SN. Microvessel stenosis, enlarged perivascular spaces, and fibrinogen deposition are associated with ischemic periventricular white matter hyperintensities. Brain Pathol 2021;:e13017. [PMID: 34538024 DOI: 10.1111/bpa.13017] [Reference Citation Analysis]
241 Beishon L, Panerai RB. The Neurovascular Unit in Dementia: An Opinion on Current Research and Future Directions. Front Aging Neurosci 2021;13:721937. [PMID: 34393765 DOI: 10.3389/fnagi.2021.721937] [Reference Citation Analysis]
242 Uprety A, Kang Y, Kim SY. Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders. Arch Pharm Res 2021;44:487-98. [PMID: 34028650 DOI: 10.1007/s12272-021-01332-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
243 Chen XR, Shao Y, Sadowski MJ; Alzheimer’s Disease Neuroimaging Initiative. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression. J Alzheimers Dis 2021;82:921-37. [PMID: 34120907 DOI: 10.3233/JAD-210434] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
244 Ouyang F, Jiang Z, Chen X, Chen Y, Wei J, Xing S, Zhang J, Fan Y, Zeng J. Is Cerebral Amyloid-β Deposition Related to Post-stroke Cognitive Impairment? Transl Stroke Res 2021. [PMID: 34195928 DOI: 10.1007/s12975-021-00921-5] [Reference Citation Analysis]
245 Zou C, Mifflin L, Hu Z, Zhang T, Shan B, Wang H, Xing X, Zhu H, Adiconis X, Levin JZ, Li F, Liu CF, Liu JS, Yuan J. Reduction of mNAT1/hNAT2 Contributes to Cerebral Endothelial Necroptosis and Aβ Accumulation in Alzheimer's Disease. Cell Rep 2020;33:108447. [PMID: 33296651 DOI: 10.1016/j.celrep.2020.108447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
246 Park L, Zhou J, Koizumi K, Wang G, Anfray A, Ahn SJ, Seo J, Zhou P, Zhao L, Paul S, Anrather J, Iadecola C. tPA Deficiency Underlies Neurovascular Coupling Dysfunction by Amyloid-β. J Neurosci 2020;40:8160-73. [PMID: 32928888 DOI: 10.1523/JNEUROSCI.1140-20.2020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
247 Chernick D, Zhong R, Li L. The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer's Disease. Biomolecules 2020;10:E1276. [PMID: 32899606 DOI: 10.3390/biom10091276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
248 Medina-Flores F, Hurtado-Alvarado G, Deli MA, Gómez-González B. The Active Role of Pericytes During Neuroinflammation in the Adult Brain. Cell Mol Neurobiol 2022. [PMID: 35195811 DOI: 10.1007/s10571-022-01208-5] [Reference Citation Analysis]
249 Blanchard JW, Victor MB, Tsai LH. Dissecting the complexities of Alzheimer disease with in vitro models of the human brain. Nat Rev Neurol 2021. [PMID: 34750588 DOI: 10.1038/s41582-021-00578-6] [Reference Citation Analysis]
250 Zhou X, Fu AK, Ip NY. APOE signaling in neurodegenerative diseases: an integrative approach targeting APOE coding and noncoding variants for disease intervention. Curr Opin Neurobiol 2021;69:58-67. [PMID: 33647674 DOI: 10.1016/j.conb.2021.02.001] [Reference Citation Analysis]
251 Gentreau M, Raymond M, Samieri C, Chuy V, Féart C, Berticat C, Artero S. Dietary Glycemic Load and Plasma Amyloid-β Biomarkers of Alzheimer's Disease. Nutrients 2022;14:2485. [PMID: 35745215 DOI: 10.3390/nu14122485] [Reference Citation Analysis]
252 Bryant AG, Hu M, Carlyle BC, Arnold SE, Frosch MP, Das S, Hyman BT, Bennett RE. Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease. Front Neurol 2020;11:575953. [PMID: 33041998 DOI: 10.3389/fneur.2020.575953] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
253 Nikolakopoulou AM, Wang Y, Ma Q, Sagare AP, Montagne A, Huuskonen MT, Rege SV, Kisler K, Dai Z, Körbelin J, Herz J, Zhao Z, Zlokovic BV. Endothelial LRP1 protects against neurodegeneration by blocking cyclophilin A. J Exp Med 2021;218:e20202207. [PMID: 33533918 DOI: 10.1084/jem.20202207] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
254 Li S, Wang C, Wang Z, Tan J. Involvement of cerebrovascular abnormalities in the pathogenesis and progression of Alzheimer's disease: an adrenergic approach. Aging (Albany NY) 2021;13:21791-806. [PMID: 34479211 DOI: 10.18632/aging.203482] [Reference Citation Analysis]
255 Dumitrascu OM, Lyden PD, Torbati T, Sheyn J, Sherzai A, Sherzai D, Sherman DS, Rosenberry R, Cheng S, Johnson KO, Czeszynski AD, Verdooner S, Frautschy S, Black KL, Koronyo Y, Koronyo-Hamaoui M. Sectoral segmentation of retinal amyloid imaging in subjects with cognitive decline. Alzheimers Dement (Amst) 2020;12:e12109. [PMID: 33015311 DOI: 10.1002/dad2.12109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
256 Choi HI, Kim K, Lee J, Chang Y, Rhee HY, Park S, Lee WI, Choe W, Ryu CW, Jahng GH. Relationship between Brain Tissue Changes and Blood Biomarkers of Cyclophilin A, Heme Oxygenase-1, and Inositol-Requiring Enzyme 1 in Patients with Alzheimer's Disease. Diagnostics (Basel) 2021;11:740. [PMID: 33919311 DOI: 10.3390/diagnostics11050740] [Reference Citation Analysis]
257 Yasuda K, Ayaki T, Li F, Kuwata Y, Maki T, Sainouchi M, Moriyoshi K, Nakamura M, Takahashi R. White matter edematous change with moderate vascular lesions in pretreated acute stage of leukoencephalopathy with cerebral amyloid angiopathy. Neuropathology 2022. [PMID: 35037303 DOI: 10.1111/neup.12782] [Reference Citation Analysis]
258 Theoharides TC. Ways to Address Perinatal Mast Cell Activation and Focal Brain Inflammation, including Response to SARS-CoV-2, in Autism Spectrum Disorder. J Pers Med 2021;11:860. [PMID: 34575637 DOI: 10.3390/jpm11090860] [Reference Citation Analysis]
259 Mai-Morente SP, Marset VM, Blanco F, Isasi EE, Abudara V. A nuclear fluorescent dye identifies pericytes at the neurovascular unit. J Neurochem 2021;157:1377-91. [PMID: 32974913 DOI: 10.1111/jnc.15193] [Reference Citation Analysis]
260 Leaston J, Ferris CF, Kulkarni P, Chandramohan D, van de Ven AL, Qiao J, Timms L, Sepulcre J, El Fakhri G, Ma C, Normandin MD, Gharagouzloo C. Neurovascular imaging with QUTE-CE MRI in APOE4 rats reveals early vascular abnormalities. PLoS One 2021;16:e0256749. [PMID: 34449808 DOI: 10.1371/journal.pone.0256749] [Reference Citation Analysis]
261 Du M, Wang X, Ma F, Li F, Li H, Li F, Zhang A, Gao Y. Association between T-tau protein and Aβ42 in plasma neuronal-derived exosomes and cognitive impairment in patients with permanent atrial fibrillation and the role of anticoagulant therapy and inflammatory mechanisms. J Card Surg 2022. [PMID: 35106827 DOI: 10.1111/jocs.16248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
262 Cacciottolo M, Morgan TE, Finch CE. Age, sex, and cerebral microbleeds in EFAD Alzheimer disease mice. Neurobiol Aging 2021;103:42-51. [PMID: 33813349 DOI: 10.1016/j.neurobiolaging.2021.02.020] [Reference Citation Analysis]
263 Boots EA, Feinstein DL, Leurgans S, Aiken-Morgan AT, Fleischman DA, Lamar M, Barnes LL. Acute versus chronic inflammatory markers and cognition in older black adults: Results from the Minority Aging Research Study. Brain Behav Immun 2022;103:163-70. [PMID: 35439553 DOI: 10.1016/j.bbi.2022.04.014] [Reference Citation Analysis]
264 Quan W, Luo Q, Hao W, Tomic I, Furihata T, Schulz-Schäffer W, Menger MD, Fassbender K, Liu Y. Haploinsufficiency of microglial MyD88 ameliorates Alzheimer's pathology and vascular disorders in APP/PS1-transgenic mice. Glia 2021;69:1987-2005. [PMID: 33934399 DOI: 10.1002/glia.24007] [Reference Citation Analysis]
265 Li J, Kong J, Ma S, Li J, Mao M, Chen K, Chen Z, Zhang J, Chang Y, Yuan H, Liu T, Zhang Z, Xing G. Exosome‐Coated 10 B Carbon Dots for Precise Boron Neutron Capture Therapy in a Mouse Model of Glioma In Situ. Adv Funct Mater 2021;31:2100969. [DOI: 10.1002/adfm.202100969] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
266 Frank CJ, McNay EC. Breakdown of the blood-brain barrier: A mediator of increased Alzheimer's risk in patients with metabolic disorders? J Neuroendocrinol 2021;:e13074. [PMID: 34904299 DOI: 10.1111/jne.13074] [Reference Citation Analysis]
267 Reichert CO, Levy D, Bydlowski SP. Paraoxonase Role in Human Neurodegenerative Diseases. Antioxidants (Basel) 2020;10:E11. [PMID: 33374313 DOI: 10.3390/antiox10010011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
268 Keep RF, Jones HC, Drewes LR. Brain Barriers and brain fluids research in 2020 and the fluids and barriers of the CNS thematic series on advances in in vitro modeling of the blood-brain barrier and neurovascular unit. Fluids Barriers CNS 2021;18:24. [PMID: 34020685 DOI: 10.1186/s12987-021-00258-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
269 Emrani S, Arain HA, DeMarshall C, Nuriel T. APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer's disease: a systematic review. Alzheimers Res Ther 2020;12:141. [PMID: 33148345 DOI: 10.1186/s13195-020-00712-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
270 Fernandez-Klett F, Brandt L, Fernández-Zapata C, Abuelnor B, Middeldorp J, Sluijs JA, Curtis M, Faull R, Harris LW, Bahn S, Hol EM, Priller J. Denser brain capillary network with preserved pericytes in Alzheimer's disease. Brain Pathol 2020;30:1071-86. [PMID: 32876357 DOI: 10.1111/bpa.12897] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
271 Tsukita K, Sakamaki-Tsukita H, Takahashi R. Lower Circulating Lymphocyte Count Predicts ApoE ε4-Related Cognitive Decline in Parkinson's Disease. Mov Disord 2021. [PMID: 34647353 DOI: 10.1002/mds.28799] [Reference Citation Analysis]
272 Imbimbo BP, Ippati S, Watling M, Balducci C. Accelerating Alzheimer's disease drug discovery and development: what's the way forward? Expert Opin Drug Discov 2021;16:727-35. [PMID: 33653187 DOI: 10.1080/17460441.2021.1887132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
273 Zhao M, Jiang XF, Zhang HQ, Sun JH, Pei H, Ma LN, Cao Y, Li H. Interactions between glial cells and the blood-brain barrier and their role in Alzheimer's disease. Ageing Res Rev 2021;72:101483. [PMID: 34610479 DOI: 10.1016/j.arr.2021.101483] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
274 Shelly S, Liraz Zaltsman S, Ben-Gal O, Dayan A, Ganmore I, Shemesh C, Atrakchi D, Garra S, Ravid O, Rand D, Israelov H, Alon T, Lichtenstein G, Sharabi S, Last D, Gosselet F, Rosen V, Burstein G, Friedlander A, Harel R, Vogel G, Schnaider Beeri M, Mardor Y, Lampl Y, Fleminger G, Cooper I. Potential neurotoxicity of titanium implants: Prospective, in-vivo and in-vitro study. Biomaterials 2021;276:121039. [PMID: 34352627 DOI: 10.1016/j.biomaterials.2021.121039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
275 Blevins BL, Vinters HV, Love S, Wilcock DM, Grinberg LT, Schneider JA, Kalaria RN, Katsumata Y, Gold BT, Wang DJJ, Ma SJ, Shade LMP, Fardo DW, Hartz AMS, Jicha GA, Nelson KB, Magaki SD, Schmitt FA, Teylan MA, Ighodaro ET, Phe P, Abner EL, Cykowski MD, Van Eldik LJ, Nelson PT. Brain arteriolosclerosis. Acta Neuropathol 2021;141:1-24. [PMID: 33098484 DOI: 10.1007/s00401-020-02235-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 30.0] [Reference Citation Analysis]
276 Zhou Y, Zhu F, Liu Y, Zheng M, Wang Y, Zhang D, Anraku Y, Zou Y, Li J, Wu H, Pang X, Tao W, Shimoni O, Bush AI, Xue X, Shi B. Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer's disease therapy. Sci Adv 2020;6:eabc7031. [PMID: 33036977 DOI: 10.1126/sciadv.abc7031] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
277 Galea I. The blood-brain barrier in systemic infection and inflammation. Cell Mol Immunol 2021;18:2489-501. [PMID: 34594000 DOI: 10.1038/s41423-021-00757-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 Palmer JA, Kaufman CS, Vidoni ED, Honea RA, Burns JM, Billinger SA. Cerebrovascular response to exercise interacts with individual genotype and amyloid-beta deposition to influence response inhibition with aging. Neurobiology of Aging 2022. [DOI: 10.1016/j.neurobiolaging.2022.02.014] [Reference Citation Analysis]
279 Norwitz NG, Saif N, Ariza IE, Isaacson RS. Precision Nutrition for Alzheimer's Prevention in ApoE4 Carriers. Nutrients 2021;13:1362. [PMID: 33921683 DOI: 10.3390/nu13041362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
280 Liao FF, Lin G, Chen X, Chen L, Zheng W, Raghow R, Zhou FM, Shih AY, Tan XL. Endothelial Nitric Oxide Synthase-Deficient Mice. Am J Pathol 2021:S0002-9440(21)00102-4. [PMID: 33711310 DOI: 10.1016/j.ajpath.2021.02.022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
281 Regy M, Dugravot A, Sabia S, Fayosse A, Mangin JF, Chupin M, Fischer C, Bouteloup V, Dufouil C, Chêne G, Paquet C, Hanseeuw B, Singh-Manoux A, Dumurgier J; MEMENTO cohort Study Group. Association of APOE ε4 with cerebral gray matter volumes in non-demented older adults: the MEMENTO cohort study. Neuroimage 2022;:118966. [PMID: 35122970 DOI: 10.1016/j.neuroimage.2022.118966] [Reference Citation Analysis]
282 Varesi A, Carrara A, Pires VG, Floris V, Pierella E, Savioli G, Prasad S, Esposito C, Ricevuti G, Chirumbolo S, Pascale A. Blood-Based Biomarkers for Alzheimer's Disease Diagnosis and Progression: An Overview. Cells 2022;11:1367. [PMID: 35456047 DOI: 10.3390/cells11081367] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
283 Panitch R, Hu J, Xia W, Bennett DA, Stein TD, Farrer LA, Jun GR. Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease. Alzheimers Res Ther 2022;14:30. [PMID: 35139885 DOI: 10.1186/s13195-022-00975-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
284 Green C, Shen X, Stevenson AJ, Conole ELS, Harris MA, Barbu MC, Hawkins EL, Adams MJ, Hillary RF, Lawrie SM, Evans KL, Walker RM, Morris SW, Porteous DJ, Wardlaw JM, Steele JD, Waiter GD, Sandu AL, Campbell A, Marioni RE, Cox SR, Cavanagh J, McIntosh AM, Whalley HC. Structural brain correlates of serum and epigenetic markers of inflammation in major depressive disorder. Brain Behav Immun 2021;92:39-48. [PMID: 33221487 DOI: 10.1016/j.bbi.2020.11.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
285 Zheng LJ, Lin L, Schoepf UJ, Varga-Szemes A, Savage RH, Zhang H, Wang YF, Zhang XY, Luo S, Liu Y, Yang GF, Lu GM, Zhang LJ. Different posterior hippocampus and default mode network modulation in young APOE ε4 carriers: a functional connectome-informed phenotype longitudinal study. Mol Neurobiol 2021;58:2757-69. [PMID: 33496907 DOI: 10.1007/s12035-021-02292-2] [Reference Citation Analysis]
286 Montagne A, Nikolakopoulou AM, Huuskonen MT, Sagare AP, Lawson EJ, Lazic D, Rege SV, Grond A, Zuniga E, Barnes SR, Prince J, Sagare M, Hsu C, Ladu MJ, Jacobs RE, Zlokovic BV. APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer’s mice via cyclophilin A independently of amyloid-β. Nat Aging 2021;1:506-20. [DOI: 10.1038/s43587-021-00073-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
287 Mishra A, Wang Y, Yin F, Vitali F, Rodgers KE, Soto M, Mosconi L, Wang T, Brinton RD. A tale of two systems: Lessons learned from female mid-life aging with implications for Alzheimer's prevention & treatment. Ageing Res Rev 2022;74:101542. [PMID: 34929348 DOI: 10.1016/j.arr.2021.101542] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
288 Chen X, Yang J, Zhang H, Huang Y, Cao Y, Yan S, Zong G, Zheng Y, Wang X, Yuan C. Plasma folate levels in relation to cognitive impairment: a community-based cohort of older adults in China. Eur J Nutr 2022. [PMID: 35303753 DOI: 10.1007/s00394-022-02825-y] [Reference Citation Analysis]
289 Coughlan G, Larsen R, Kim M, White D, Gillings R, Irvine M, Scholey A, Cohen N, Legido-Quigley C, Hornberger M, Minihane AM. APOE ε4 alters associations between docosahexaenoic acid and preclinical markers of Alzheimer's disease. Brain Commun 2021;3:fcab085. [PMID: 34007965 DOI: 10.1093/braincomms/fcab085] [Reference Citation Analysis]
290 Wang Y, Kisler K, Nikolakopoulou AM, Fernandez JA, Griffin JH, Zlokovic BV. 3K3A-Activated Protein C Protects the Blood-Brain Barrier and Neurons From Accelerated Ischemic Injury Caused by Pericyte Deficiency in Mice. Front Neurosci 2022;16:841916. [DOI: 10.3389/fnins.2022.841916] [Reference Citation Analysis]
291 Saiyasit N, Butlig ER, Chaney SD, Traylor MK, Hawley NA, Randall RB, Bobinger HV, Frizell CA, Trimm F, Crook ED, Lin M, Hill BD, Keller JL, Nelson AR. Neurovascular Dysfunction in Diverse Communities With Health Disparities-Contributions to Dementia and Alzheimer's Disease. Front Neurosci 2022;16:915405. [PMID: 35844216 DOI: 10.3389/fnins.2022.915405] [Reference Citation Analysis]
292 Pyun JM, Park YH, Lee KJ, Kim S, Saykin AJ, Nho K; Alzheimer’s Disease Neuroimaging Initiative. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment. Transl Neurodegener 2021;10:32. [PMID: 34465370 DOI: 10.1186/s40035-021-00259-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
293 Fontaine JT, Rosehart AC, Joutel A, Dabertrand F. HB-EGF depolarizes hippocampal arterioles to restore myogenic tone in a genetic model of small vessel disease. Mech Ageing Dev 2020;192:111389. [PMID: 33127441 DOI: 10.1016/j.mad.2020.111389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
294 Wu KM, Zhang YR, Huang YY, Dong Q, Tan L, Yu JT. The role of the immune system in Alzheimer's disease. Ageing Res Rev 2021;70:101409. [PMID: 34273589 DOI: 10.1016/j.arr.2021.101409] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
295 Buckley RF. Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease. Neurotherapeutics 2021. [PMID: 33782864 DOI: 10.1007/s13311-021-01026-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
296 Qi Y, Wei S, Xin T, Huang C, Pu Y, Ma J, Zhang C, Liu Y, Lynch I, Liu S. Passage of exogeneous fine particles from the lung into the brain in humans and animals. Proc Natl Acad Sci U S A 2022;119:e2117083119. [PMID: 35737841 DOI: 10.1073/pnas.2117083119] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
297 Yu G, Zhang Y, Ning B. Reactive Astrocytes in Central Nervous System Injury: Subgroup and Potential Therapy. Front Cell Neurosci 2021;15:792764. [PMID: 35002629 DOI: 10.3389/fncel.2021.792764] [Reference Citation Analysis]
298 Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol 2021;20:68-80. [PMID: 33340485 DOI: 10.1016/S1474-4422(20)30412-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 27.0] [Reference Citation Analysis]
299 Yang AC, Vest RT, Kern F, Lee DP, Agam M, Maat CA, Losada PM, Chen MB, Schaum N, Khoury N, Toland A, Calcuttawala K, Shin H, Pálovics R, Shin A, Wang EY, Luo J, Gate D, Schulz-schaeffer WJ, Chu P, Siegenthaler JA, Mcnerney MW, Keller A, Wyss-coray T. A human brain vascular atlas reveals diverse mediators of Alzheimer’s risk. Nature. [DOI: 10.1038/s41586-021-04369-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 14] [Article Influence: 34.0] [Reference Citation Analysis]
300 Ingala S, De Boer C, Masselink LA, Vergari I, Lorenzini L, Blennow K, Chételat G, Di Perri C, Ewers M, van der Flier WM, Fox NC, Gispert JD, Haller S, Molinuevo JL, Muniz-Terrera G, Mutsaerts HJ, Ritchie CW, Ritchie K, Schmidt M, Schwarz AJ, Vermunt L, Waldman AD, Wardlaw J, Wink AM, Wolz R, Wottschel V, Scheltens P, Visser PJ, Barkhof F; EPAD consortium. Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort. Alzheimers Dement 2021;17:1189-204. [PMID: 33811742 DOI: 10.1002/alz.12292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
301 Gorbach T, Pudas S, Bartrés-Faz D, Brandmaier AM, Düzel S, Henson RN, Idland AV, Lindenberger U, Macià Bros D, Mowinckel AM, Solé-Padullés C, Sørensen Ø, Walhovd KB, Watne LO, Westerhausen R, Fjell AM, Nyberg L. Longitudinal association between hippocampus atrophy and episodic-memory decline in non-demented APOE ε4 carriers. Alzheimers Dement (Amst) 2020;12:e12110. [PMID: 33015312 DOI: 10.1002/dad2.12110] [Reference Citation Analysis]
302 Akhter F, Persaud A, Zaokari Y, Zhao Z, Zhu D. Vascular Dementia and Underlying Sex Differences. Front Aging Neurosci 2021;13:720715. [PMID: 34566624 DOI: 10.3389/fnagi.2021.720715] [Reference Citation Analysis]
303 Wasielewska JM, Da Silva Chaves JC, White AR, Oikari LE; Mental Health Program, Cell and Molecular Biology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia, Mental Health Program, Cell and Molecular Biology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia, Mental Health Program, Cell and Molecular Biology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia, Mental Health Program, Cell and Molecular Biology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia, Mental Health Program, Cell and Molecular Biology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. Modeling the Blood–Brain Barrier to Understand Drug Delivery in Alzheimer’s Disease. In: Huang X, editor. Alzheimer’s Disease: Drug Discovery. Exon Publications; 2020. pp. 117-34. [DOI: 10.36255/exonpublications.alzheimersdisease.2020.ch7] [Reference Citation Analysis]
304 Abate G, Memo M, Uberti D. Impact of COVID-19 on Alzheimer's Disease Risk: Viewpoint for Research Action. Healthcare (Basel) 2020;8:E286. [PMID: 32839380 DOI: 10.3390/healthcare8030286] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
305 Shi H, Koronyo Y, Rentsendorj A, Fuchs DT, Sheyn J, Black KL, Mirzaei N, Koronyo-Hamaoui M. Retinal Vasculopathy in Alzheimer's Disease. Front Neurosci 2021;15:731614. [PMID: 34630020 DOI: 10.3389/fnins.2021.731614] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
306 Bracko O, Cruz Hernández JC, Park L, Nishimura N, Schaffer CB. Causes and consequences of baseline cerebral blood flow reductions in Alzheimer's disease. J Cereb Blood Flow Metab 2021;41:1501-16. [PMID: 33444096 DOI: 10.1177/0271678X20982383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
307 Miranda AM, Ashok A, Chan RB, Zhou B, Xu Y, Mcintire LB, Area-gomez E, Di Paolo G, Duff KE, Oliveira TG, Nuriel T. Effects of APOE4 allelic dosage on lipidomic signatures in the entorhinal cortex of aged mice. Transl Psychiatry 2022;12. [DOI: 10.1038/s41398-022-01881-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
308 Ni R. Positron Emission Tomography in Animal Models of Alzheimer's Disease Amyloidosis: Translational Implications. Pharmaceuticals (Basel) 2021;14:1179. [PMID: 34832961 DOI: 10.3390/ph14111179] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
309 Kung Y, Hsiao MY, Yang SM, Wen TY, Chen M, Liao WH, Wu CH, Ao L, Chen WS. A single low-energy shockwave pulse opens blood-cerebrospinal fluid barriers and facilitates gastrodin delivery to alleviate epilepsy. Ultrason Sonochem 2021;78:105730. [PMID: 34464899 DOI: 10.1016/j.ultsonch.2021.105730] [Reference Citation Analysis]
310 Masdeu JC, Pascual B, Fujita M. Imaging Neuroinflammation in Neurodegenerative Disorders. J Nucl Med 2022;63:45S-52S. [PMID: 35649654 DOI: 10.2967/jnumed.121.263200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
311 Pontifex MG, Malik MMAH, Connell E, Müller M, Vauzour D. Citrus Polyphenols in Brain Health and Disease: Current Perspectives. Front Neurosci 2021;15:640648. [PMID: 33679318 DOI: 10.3389/fnins.2021.640648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
312 Procter TV, Williams A, Montagne A. Interplay between brain pericytes and endothelial cells in dementia. Am J Pathol 2021:S0002-9440(21)00340-0. [PMID: 34329605 DOI: 10.1016/j.ajpath.2021.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
313 Vecchio FL, Bisceglia P, Imbimbo BP, Lozupone M, Latino RR, Resta E, Leone M, Solfrizzi V, Greco A, Daniele A, Watling M, Panza F, Seripa D. Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease? Therapeutic Advances in Chronic Disease 2022;13:204062232210816. [DOI: 10.1177/20406223221081605] [Reference Citation Analysis]